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 1 
Zusammenfassung 
 
Polysialinsäure (PolySia) ist ein lineares Homopolysachcharid aus a2,8-verknüpften 
Sialinsäureeinheiten. Als dynamisch regulierte posttranslationale Modifikation des Neuralen 
Zelladhäsionsmoleküls NCAM übernimmt die PolySia eine wichtige Rolle in der Regulation 
interzellulärer Erkennungs- und Adhäsionsvorgänge. Durch eine hohe negative 
Oberflächenladungsdichte hat PolySia eine hohe Wasserbindungskapazität. Die daraus 
resultierende Größe des NCAMs wird als wichtigster Regulator zellulärer Interaktionen 
betrachtet. PolySia unterstützt motile Prozesse wie z.B. Migration, axona les Wachstum aber 
auch axonale Wegfindung, Neurogenese und Regeneration. PolySia wird in einigen hoch 
malignen Tumoren exprimiert. Es wird angenommen, dass die Motilität-unterstützenden 
Eigenschaften des Zuckers für das hohe Metastasierungspotential dieser Tumore 
verantwortlich sind.  
Die Schlüsselenzyme der PolySia Biosynthese sind die Polysialyltransferasen (PolySTs), 
ST8SiaII und ST8SiaIV. PolySTs sind Golgi residente Typ-II-Transmembranproteine und 
besitzen eine kurze N-terminale cytoplasmatische Domäne sowie eine katalytische Domäne, 
die im Golgilumen positioniert ist. PolySTs sind Glykoproteine mit sechs bzw. fünf N-
Glykanen. Beide Enzyme sind in der Lage die eigenen N-Glykane durch die Addition von 
PolySia zu modifizieren, was als Autopolysialylierung bezeichnet wird. Eine frühere Arbeit 
unserer Gruppe hat gezeigt, dass nur solche Enzymformen aktiv sind, die die Fähigkeit zur 
Autopolysialylierung besitzen. Die Tatsache, dass sowohl N-Glykane als auch 
Disulfidbrücken für die Herstellung aktiver eukaryontischer PolySTs notwendig sind, stellt 
eine bedeutende Barriere für die Expression des rekombinanten Proteins dar und beschränkt 
die Expression auf eukaryontischen Expressionssysteme. In diesen konnten allerdings bislang 
keine ausreichenden PolyST-Mengen hergestellt werden, um deren Struktur-
Funktionszusammenhänge näher zu analysieren.  
Ziel meiner Doktorarbeit war es, Wege zu finden, die die Herstellung funktionell aktiver 
rekombinanter polySTs verbessern. Eine bioinformatischen Analyse ergab, dass in ST8SiaII 
aus Zebrafisch (zST8SiaII) eine der hoch konservierten und für die Funktion der homologen 
Enzyme essentiellen N-Glykosylierungsstellen fehlt. Dieses Protein wurde deshalb als Modell 
verwendet, um in iterativen Schritten alle N-Glykosylierungsstellen zu inaktivieren und über 
N-terminale Verkürzungen das minimal aktive Protein darzustellen. Auf diesem Weg konnte 
eine lösliche und aktive Variante des Enzyms hergestellt werden. Die N-terminal verkürzte 
Enzymvariante zST8SiaII? N86 konnte in Insektenzellen als hoch reines Protein im 
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Milligrammbereich hergestellt und für erste Struktur-Funktions-Analysen über NMR-
Spektroskopie eingesetzt werden. 
In einem weiteren Ansatz wurde die ST8SiaII aus der Maus als Modellenzym eingesetzt und 
der Versuch unternommen, vorhandene N-Glykane durch Motive auszutauschen, die in 
Knochenfischen als „Ersatz“ für N-Glykane identifiziert worden waren. Dadurch gelang die 
Herstellung einer N-Glykan-freien Variante. Erste Versuche, dieses Protein in 
Bakterienzellen zu exprimieren, ergaben zwar sehr gute Proteinausbeuten, allerdings zeigte 
das rekombinant hergestellte Protein nur eine geringe Stabilität und keine Aktivität. Einen 
wesentlichen Anteil am Fehlen von Stabilität und Funktion in diesem Enzym könnte die 
unvollständige Ausbildung der Disulfidbrücken haben. In weiteren Untersuchungen soll nun 
die Optimierung des Proteins vorangetrieben werden. 
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Abstract 
 
Polysialic acid (polySia) is a linear homopolymer consisting of a-2,8 linked sialic acid 
building blocks. The polymer predominately occurs as dynamically regulated 
posttranslational modification of the neural cell adhesion molecule NCAM. Thus, it plays a 
major role in regulating NCAM-mediated interactions involved in cellular plasticity. The 
negative  charge of polySia causes in a large hydrodynamic volume of NCAM and 
subsequently attenuates NCAM-mediated cell-cell contacts. In line with this, polySia enables 
numerous neuronal processes such as migration, axonal outgrowth and orientation as well as 
neurogenesis up to the point of nerve regeneration. PolySia is also expressed in a number of 
highly malignant tumors, where it is supposed to increase the metastatic potential by 
enhancing the motility of tumor cells. 
PolySia is synthesized by two polysialyltransferases (polySTs): ST8SiaII and ST8SiaIV. 
Both enzymes reside in the Golgi apparatus and represent type-II-transmembrane proteins 
with a short N-terminal cytoplasmic domain and a catalytic domain extending into the Golgi 
lumen. 
PolySTs are glycoproteins with six or five putative N-glycosylation sites, respectively. Both 
enzymes, ST8SiaII and ST8SiaIV, are capable of polysialylating their own N-glycans – a 
process referred to as “autopolysialylation”. 
Results from earlier studies in our laboratory show, that only enzymes capable of 
autopolysialylation are able to polysialylate NCAM. Since neither N-Glycans nor disulfide 
bonds occur in prokaryotes, but N-glycosylation and disulfide bonds are essential for the 
formation of active polySTs, expression systems had been limited to eukaryotic cells so far. 
However, eukaryotic systems provide only very small protein yields of recombinant 
mammalian polySTs that are not sufficient to intensively analyze structure-function 
relationships. My Ph.D. thesis, therefore, is concentrated on the large-scale expression of 
functional ST8SiaII to be used to characterize polySTs in detail by applying biochemical and 
biophysical analyses. 
Former bioinformatic analyses had shown that ST8SiaII from zebrafish (zST8SiaII) is 
lacking one out of two N-glycosylation sites, identified as important for the ST8SiaII activity 
in homologues enzymes. Therefore, this enzyme was used as a model to determine the 
minimal length of the active enzyme and the impact of N-glycans on activity. As a result, a 
soluble and active variant of the enzyme was generated and purified in milligram quantities 
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from insect cells. Consequently, the analysis of structure-function relationship by NMR-
spectroscopy has been commenced. 
The second goal of my PhD study was the generation of a murine ST8SiaII variant with no- 
or a minimal number of N-glycans. This was achieved by substituting the N-glycan functions 
by motifs found instead of N-glycans in the bony-fish family. N-glycan free mST8SiaII 
variants were generated that allowed soluble expression using a bacterial system. 
Unfortunately, the recombinant protein produced in bacteria was - probably due to the lack of 
disulfide bonds - inactive and quickly degraded. Further studies will be focused on the 
optimization of murine ST8SiaII for a subsequent expression in bacteria. 
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General Introduction 
 
Polysialic acid 
 
In vertebrates the term polysialic acid (polySia) describes a linear homopolymer of a2,8- 
linked sialic acid (Sia) residues. The monomeric building block Sia is a nine-carbon sugar 
with a carboxylic acid function at position C1. So far, more than 50 naturally occurring Sia 
derivatives have been identified in various kingdoms of life (including vertebrates, 
invertebrates and bacteria). All sialic acids are derived from the monosaccharide 2-keto-3-
deoxy-5-acetamido-D-glycero-D-galacto-nonulosonic acid (acetylneuraminic acid, Neu5Ac) 
(Angata and Varki, 2002; Varki and Varki, 2007). Remarkably, only three monomers have 
been identified in polySia: N-acetylneuraminic acid (Neu5Ac), N-glycolylneuraminic acid 
(Neu5Gc) and 2-keto-3-deoxy-D-glycero-D-galacto-nonulosonic acid (Kdn) (Troy, 1992). 
The linear homopolysaccharide as well as the three Sia derivatives present in polySia are 
shown in figure 1. 
 
 
Figure 1: Chemical structures. A. Structure of a2,8-linked polysialic acid (polySia). B. Structures of 
N-acetylneuraminc acid (Neu5Ac), N-glycolylneuramininic acid (Neu5Gc) und deamino-neuraminic 
acid (2-Keto-3-deoxy-D-glycero-D-galacto-nonulosonsäure, Kdn). 
 
Under physiological conditions polySia is negatively charged due to the carboxylate function 
at position C1 of each monomer. The polyanionic nature of polySia involves high water 
binding capacity resulting in a large hydrodynamic volume (Yang, Yin, and Rutishauser, 
1992). Based on NMR-studies, polySia in solution is assumed to exhibit a helical 
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conformation, with approximately nine residues per turn (Brisson et al., 1992). PolySia 
chains with a polymerization degree (Dp) higher than above eleven were shown to form 
filamentous networks (Toikka et al., 1998). 
Several neuroinvasive bacteria such as E. coli K1 and N. meningitidis serogroup B are 
protected by an extracellular polysaccharide capsule composed of polySia (Troy, 1992). In 
vertebrates, polySia forms a posttranslational modification of the neural cell adhesion 
molecule (NCAM) (Rothbard et al., 1982). For many years NCAM was assumed to be the 
only polySia carrier in the mammalian system. However, more recent studies have provided 
evidence that other polySia carriers exist. Additional polySia carrying proteins include the a 
subunit of the voltage dependent sodium channel (Zuber et al., 1992), the scavenger receptor 
CD36, identified as soluble protein in human breast milk (Yabe et al., 2003) and, as shown in 
a most recent study, neuropilin-2 expressed on matured dendritic cells (Curreli et al., 2007). 
 
 
Function of polySia in vertebrates 
 
As mentioned above, NCAM, a membrane bound glycoprotein belonging to the family of 
immunoglobuline- like proteins, is the major polySia carrier in vertebrates. The three major 
isoforms NCAM-180, NCAM-140 and NCAM-120 (fig. 2) are characterized by their 
respective molecular mass arising from alternative splicing of a single gene (Cunningham et 
al., 1987; Kolkova, 2008).  
NCAM contains five immunoglobuline (Ig)- like domains and two fibronectin type-III 
(FNIII)- like repeats in the extracellular domain. NCAM-180 and NCAM-140 are 
transmembrane proteins varying in the length of their intracellular domain (fig. 2) whereas 
NCAM-120 is  a glycosyl-phosphatidylinositol (GPI)-anchored protein (Cunningham et al., 
1987). Six N-glycosylation sites are located within the extracellular Ig-like domains 3-5. 
Interestingly, polysialylation occurs exclusively at N-glycosylation site 5 and 6 located in the 
fifth Ig-like domain (Nelson, Bates, and Rutishauser, 1995; Liedtke et al., 2001). Further 
modifications of NCAM such as O-glycosylation were reported for an isoform found in 
skeletal muscle myotubes (Walsh et al., 1989) and for NCAM variations co-expressed with 
the polySia-synthesizing enzyme in cell culture (Close et al., 2003; Colley, 2008). 
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Figure 2: Scheme of the three major NCAM isoforms and the polysialylated from of NCAM 
(reprint Hildebrandt, Mühlenhoff, and Gerardy-Schahn, 2008). A. The extracellular part of 
NCAM is composed of five immunoglobulin (Ig)-like domains and two fibronectin type III (FNIII) 
like repeats. NCAM is a glycoprotein with in total six  N-glycosylation sites. B. Transfer of polySia to 
NCAM involves two N-glycan sites (no. 5 and 6) in the 5th Ig-domain. The presence of polySia 
increases the hydrodynamic radius of NCAM as illustrated by the shaded sphere. 
 
NCAM was first reported as calcium independent homophilic adhesion molecule abundantly 
expressed in the nervous system (Rutishauser, Hoffman, and Edelman, 1982; Hinsby, 
Berezin, and Bock, 2004). Like other cell adhesion molecules, NCAM participates in 
signaling pathways by homo- or heterophilic interactions of the extracellular domain. For 
instance, heterophilic interaction of NCAM and the fibroblast growth factor receptor (FGFR) 
activates a signal cascade to promote axonal outgrowth (Saffell et al., 1997). Down-
regulation of NCAM-mediated cell adhesion by association of NCAM with the glial-derived 
neurotrophic factor family receptor a (GFRa) results in Schwann cell migration and axonal 
growth in hippocampal and cortical neurons (Paratcha, Ledda, and Ibanez, 2003). 
Another possibility of NCAM to modulate signaling pathways is mediated by polySia. In the 
presence of the negatively charged sugar polymer, hippocampal and hypothalamic neurons 
are more sensitive to the brain-derived neurotrophic factor (BDNF) (Muller et al., 2000; 
Vutskits et al., 2001). Accordingly, in vivo experiments demonstrated that enzymatic removal 
of polySia from NCAM or application of soluble polySia from exogenous sources affect 
physiological functions as e.g. long-term potentiation (LTP) in the hippocampus and that 
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these effects could be rescued by external addition of BDNF (Muller et al., 2000). To explain 
this so-called “positive” regulatory effect of polySia, two models are currently discussed:  
(1) NCAM bound polySia may raise the concentration of BDNF at the receptor site or  
(2) NCAM bound polySia could decrease inhibitory effects established by NCAM/BDNF-
receptor interactions (Hildebrandt et al., 2007). 
Several findings substantiate the assumption that polySia acts as a “negative” regulator of cell 
adhesion and differentiation. The presence of bulky and highly hydrated polySia increases 
inter-membrane repulsion (Yang, Major, and Rutishauser, 1994; Rutishauser, 1998; Johnson 
et al., 2005). Based on this sterical effect, polySia is believed to weaken adhesive properties 
of cells and simultaneously facilitates cell motility. The migration-supportive effect of 
polySia seems to enable rostral migration of progenitor cells from their birthplace in the 
subventricular zone (SVZ) along a given pathway to the olfactory bulb (for review 
Rutishauser, 2008). Enzymatic removal of polySia from these progenitor cells was shown to 
inhibit their ability to migrate, accompanied by a premature differentiation of the cells. The 
induction of the differentiation process is most likely mediated by the presence of polySia 
free NCAM (Hu et al., 1996; Petridis, El Maarouf, and Rutishauser, 2004; Rockle et al., 
2008; Rutishauser, 2008). An impressive illustration for the regular functions of polySia 
during mouse development has been obtained in a mouse model with depleted polySia 
synthesis. This model demonstrates that the absence of polySia goes along with a gain of 
function for NCAM resulting in a lethal phenotype (Weinhold et al., 2005).  
This finding clearly argues for an essential role of polySia in the control and coordination of 
NCAM interactions during mouse development (Weinhold et al., 2005). In vivo analysis of 
mouse brain revealed that polySia biosynthesis starts on embryonic day 8-8.5 and the 
maximum level is reached in the perinatal phase. Thereafter a rapid decrease by 
approximately 70 % within only one week was observed (Probstmeier, Bilz, and Schneider-
Schaulies, 1994; Kurosawa et al., 1997; Oltmann-Norden et al., 2008; Hildebrandt, 
Mühlenhoff, and Gerardy-Schahn, 2008). In accordance with its function, polySia remains 
expressed in the adult brain in areas of persistent neural plasticity such as the subventricular 
zone and the rostral migratory stream (Miragall et al., 1990; Theodosis, Rougon, and Poulain, 
1991; Seki and Arai, 1993; Hu et al., 1996).  
In addition to its essential role in neural development, polySia represents a tumor marker 
(Roth et al., 1988; Fukuda, 1996). PolySia is re-expressed on several malignant 
neuroectodermal and neuroendocrine tumors, including Wilm`s tumor (Roth et al., 1988; 
Zuber et al., 2005), lung carcinoma (Scheidegger et al., 1994; Tanaka et al., 2001), 
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rhabdomyosacroma (Glüer et al., 1998b) and neuroblastoma (Glüer et al., 1998a; Hildebrandt 
et al., 1998; Seidenfaden et al., 2003). By destabilisation of cell-cell contacts polySia might 
facilitate detachment of cells during metastasis. In addition, the life span of tumor cells in 
circulation might be increased, because polySia can mask tumor specific antigens (Bitter-
Suermann and Roth, 1987) that are otherwise recognised by the immune system. In 
accordance with this hypothesis the polySia levels of two clonal sublines of a small cell lung 
carcinoma line (polySia+ and polySia-) were correlated to metastasis in xenografted nude 
mice (Scheidegger et al., 1994). Another mouse model revealed that metastasis and invasion 
of a polySia expressing rhabdomyosacroma cell line was drastically reduced after enzymatic 
removal of polySia (Daniel et al., 2001). This correlation between polySia and the tumor 
potential for metastasis was also monitored in a retrospective study of non-small cell lung 
cancer patients resulting in a worse prognosis for polySia positive patients (Tanaka et al., 
2001). 
While tumor biology provided evidence for the cell motility promoting function of polySia, 
more recent nerve regeneration studies proved these findings (El Maarouf and Rutishauser, 
2008). In general, the adult central nervous system (CNS) is unable to reverse damage 
produced by injury or disease and severed CNS axons are unable to re-grow and re- innervate 
their targets. Usually, this deficiency is not caused by an intrinsic incapacity to resume 
elongation, but reflects a non-permissiveness of the CNS environment and of scar tissue at 
lesion sites in particular (David and Aguayo, 1981; Fawcett and Asher, 1999; Batchelor and 
Howells, 2003). Therefore, the introduction of polySia into lesion sites by a viral vector, 
containing the polySia synthesizing enzyme, may create an environment that on the one hand 
supports cell motility and on the other hand reduces inhibitory effects of the CNS 
environment. Studies carried out in this field demonstrated that re-expression of polySia in 
astrocytes promotes re-growth of axons through the lesion site in spinal cord. Moreover, the 
retrieval of a polySia expressing path between the subventricular zone (SVZ) and a brain 
lesion site was demonstrated to facilitate the recruitment of progenitor cells of the SVZ to the 
damaged area (El Maarouf, Petridis, and Rutishauser, 2006; El Maarouf and Rutishauser, 
2008). 
Aiming at exploiting the axon growth promoting functions of polySia for regeneration in the 
peripheral nervous system, studies have been initiated to use the purified polymer as an 
external growth support. Experiments carried out so far demonstrate that polySia represents a 
suitable matrix for the cultivation of primary neural cells that are candidates for therapeutic 
strategies in peripheral nerve tissue reconstruction approaches. Compared to classical culture 
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conditions, significantly improved survival and proliferation rates were obtained with 
primary neuronal and glial cells (Haile et al., 2008).  
 
 
Biosynthesis of polySia 
 
As schematically shown in fig. 3, the biosynthesis of sialylated and polysialylated 
glycoconjugates involves virtually all cellular compartments. While the biosynthetic steps 
delivering sialic acid are localized in the cytosol, the metabolic activation of Sia to cytidine 
monophosphate-sialic acid (CMP-Sia) by the CMP-Sia-synthetase takes place in the cell 
nucleus (Kean, Munster-Kuhnel, and Gerardy-Schahn, 2004). A specific CMP-Sia transporter 
transfers the activated sugar into the Golgi (Eckhardt, Gotza, and Gerardy-Schahn, 1998), 
where CMP-Sia serves as a substrate for sialyl- and polysialyltransferases (Harduin-Lepers et 
al., 2001).  
 
Figure 3: Schematic representation of the polysialylation process in the eukaryotic vertebrate 
cell.  
 
The polySia biosynthesis is performed by two polysialyltransferases (polyST), ST8SiaII and 
ST8SiaIV. In early development and in the perinatal phase ST8SiaII is the predominant 
polyST whereas ST8SiaIV prevails in adult mice (Oltmann-Norden et al., 2008). Both 
polySTs are able to synthesize polySia independently of NCAM in vitro and in vivo (Angata 
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et al., 2000; Oltmann-Norden et al., 2008). In a comparative in vitro study carried out  with 
recombinant soluble polysialyltransferases, ST8SiaIV was found to be more efficient in terms 
of NCAM polysialylation. Moreover, ST8SiaIV synthesized longer polySia chains than 
ST8SiaII. Using N-glycosylation site mutants of NCAM, ST8SiaIV strongly preferred the 6th 
over the 5th N-glycosylation site, whereas this preference was only moderate for ST8SiaII. A 
synergistic effect, resulting in higher numbers of added polySia chains as well as in a higher 
degree of polymerization, was observed, if the two polySTs were acting together (Angata, 
Suzuki, and Fukuda, 1998; Angata, Suzuki, and Fukuda, 2002). 
Different from the in vitro observations, the analysis of mouse brain samples isolated from 
animals expressing only one functional polyST (ST8SiaII- and ST8SiaIV-knockout mice) 
revealed that both polySTs favor the 6th over the 5th N-glycosylation site. Synergy in this 
study could be limited to the transfer of polySia onto the 5th N-glycosylation site, where 
longer polySia cha ins were found in wild type than in single polyST knockout mice (Galuska 
et al., 2008).  
The in vivo analysis confirmed that each enzyme individually is able to synthesize long 
polySia chains (up to Dp 90). However, compared to wild-type, the percentage of long 
polySia chains was decreased to 50 % in mice expressing only ST8SiaII and to 25-33 % in 
mice expressing only ST8SiaIV (Galuska et al., 2008). Consequently, ST8SiaII knockout 
mice exhibit a different phenotype compared to ST8SiaIV knockout mice. ST8SiaII 
deficiency caused morphological changes in brain structures and altered fear conditioning, 
whereas loss of ST8SiaIV resulted in reduced learning and memory in adult mice (Angata et 
al., 2004; Eckhardt et al., 2000). Double-knockout mice of ST8SiaII and ST8SiaIV are 
characterized by a complete lack of polySia. These animals are drastically retarded in growth 
and more than 80 % die within four weeks after birth (Weinhold et al., 2005; Angata et al., 
2007). 
 
 
Polysialyltransferases 
 
The two polys ialyltransferases, ST8SiaII and ST8SiaIV, were cloned and functionally 
expressed from mouse and other species (Eckhardt et al., 1995; Nakayama et al., 1995; 
Scheidegger et al., 1995; Kojima et al., 1995; Kudo et al., 1998). Both mammalian polySTs  
belong to the a2,8-sialyltransferase protein family and share 59 % identity at the amino acid 
level (Eckhardt et al., 1995; Nakayama et al., 1995; Harduin-Lepers et al., 2005).  
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PolySTs contain the three sialyl sequence motifs, found in all a2,8-sialyltransferases 
(fig. 4 A). The L-motif (large motif) is involved in binding of the activated sugar CMP-Sia, 
whereas the S-motif (short motif) binds to CMP-Sia as well as to the acceptor substrate 
(Datta and Paulson, 1995; Datta, Sinha, and Paulson, 1998). Mutation of the VS-motif (very 
short motif) resulted in an inactive enzyme (Kitazume-Kawaguchi, Kabata, and Arita, 2001). 
For polySTs, an additional motif, the so-called polyST domain (PSTD) could be identified. 
This motif consists of 32 amino acids and is essential to establish polysialylation capacity. It 
is postulated that electrostatic interaction between the polybasic PSTD and the polyanionic 
polySia chain tether nascent polySia chains to the enzyme  and thus facilitate the processive 
addition of new Sia residues to the non-reducing end of the growing chain (Nakata, Zhang, 
and Troy, 2006). 
The polySTs contain highly conserved cysteine residues. The first cysteine (C) located in the 
L-motif and the cysteine of the S-motif form a disulfide bridge, whereas the second cysteine 
in the sialyl-motif L and the cysteine located at the very C-terminus of the enzymes form a 
second disulfide bond (fig. 4) (Angata et al., 2001). The catalytic domain of the type-II-
transmembrane polyST is located in the lumen of the Golgi-apparatus (Close and Colley, 
1998; Mühlenhoff et al., 2001).  
 
Figure 4: Schematic representation of polySTs. A. Schematic representation of ST8SiaII and 
ST8SiaIV. The large (L), small (S) and very short (SV) sialylmotifs and the polyST domain (PSTD) 
are indicated as shaded boxes. Conserved cysteines and N-glycosylation sites are marked. N-
glycosylation sites important for polyST activity are indicated by asterisk. B. Type II membrane 
topology of polySTs. Transmembrane domain (TMD), stem region (stem) and catalytic domain are 
indicated. Conserved cysteine residues and disulfide bridges are charted in. 
 
Both polySTs are glycoproteins with six and five putative N-glycan attachment sites, 
respectively. N-glycosylation occurs on all acceptor sites mentioned above, as shown by Dr. 
Mühlenhoff in our laboratory (Mühlenhoff et al., 2001). Interestingly, the N-glycans N89, 
N219, and N234 of ST8SiaII and N50, N74, and N119 of ST8SiaIV are additionally modified 
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by polysialylation, although it remains unclear whether this modification is added intra- or 
intermolecularly. This self-modification is referred to as autopolysialylation (Close et al., 
2001; Close, Tao, and Colley, 2000; Mühlenhoff et al., 2001).  
For the murine ST8SiaII, depletion of the N-glycan-attachment sites N89 and N219 by site-
directed mutagenesis of the asparagine-residue (N) in the respective consensus sequences (N-
X-S/T) resulted in a loss of autopolysialylation and in decreased NCAM-polysialylation 
activity. The same results were obtained for the deletion of N74 in ST8SiaIV (Close, Tao, 
and Colley, 2000; Close et al., 2001; Mühlenhoff et al., 2001). A complete loss of polyST 
activity was reported for the murine ST8SiaII and ST8SiaIV when all N-glycan attachment 
sites were deleted (Mühlenhoff et al., 2001). 
The transfer of polySia onto NCAM needs priming of the acceptor sites by terminal 2,3- or 
2,6-linked sialic-acid residues. Moreover, the mammalian polySTs seem to be strictly 
dependent on the way the polySia acceptor sites on NCAM are presented to the enzymes. 
Attempts to transfer polySia onto artificial non-protein acceptors dramatically reduced the 
potential of these enzymes to synthesize polySia (Angata et al., 2000; Angata, Suzuki, and 
Fukuda, 2002).  
To ascertain which parts of NCAM serve as recognition sites for polySTs, a detailed study 
has been carried out in Prof. Colley’s laboratory. In this study, deletion mutants prepared 
from NCAM showed that a construct harboring the entire FNIII-1 domain together with the 
adjacent Ig5 domain is sufficient for polySia transfer. Moreover, this group demonstrated that 
replacement of acidic patches in the NCAM FNIII-1 domain alters polysialylation. An a-
helix identified in this domain is critical for contact formation between polyST and NCAM 
and the correct presentation of the N-glycans localized in the Ig5 domain to the polySTs  
(Mendiratta et al., 2005; Mendiratta et al., 2006; Colley, 2008). However, no corresponding 
protein-recognition site could be identified in the polySTs so far.  
 
 
Evolution of polysialyltransferases  
 
The a2,8-sialyltransferase (ST8Sia) family consists of six subfamilies that all transfer Sia 
residues in an a2,8- linkage on terminally sialylated acceptors. Members of the ST8Sia-family 
can act on glycoproteins and glycolipids. The six subfamilies split into two branches, 
containing three enzymes each: ST8SiaI, V and VI in the first branch and ST8SiaII, III, and 
IV in the second branch, respectively. Members of the subfamilies localized in the first 
branch transfer only one sialic acid residue to form disialyl structures, whereas the second 
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branch contains the polysialyltransferases ST8SiaII and -IV as well as the 
oligosialyltransferase ST8SiaIII (Harduin-Lepers et al., 2005). Remarkably, an ancestor gene 
of all members of the ST8Sia family has been identified in the cephalochordate amphioxus 
(Harduin-Lepers et al., 2005). Therefore, the variety of sialyltransferases is likely to have 
evolved as a result of massive gene duplications that took place early in vertebrate evolution 
and early after fish radiation (Amores et al., 1998). 
 
 
Figure 5: Evolutionary relationships between vertebrate polysialyltransferases as recovered 
from Minimum-Evolution and Neighbor-Joining analysis (reprint Marx et al., 2007). The 
consensus tree is based on amino acid sequence alignment. Bootstrap support is shown for relevant 
nodes. The sequence identity scores (regarding their human homologue) are given in brackets beside 
the taxis label. ST8SiaII and ST8SiaIV proteins are recovered as monophyletic groups with 
comparable evolutionary dynamics, as observed in their branching pattern. The clustering of fish 
ST8SiaII differs from the one observed for fish ST8SiaIV. As fish ST8SiaIV genes differ in their 
overall dN/dS ratio, they do not cluster as a sister clade basal to tetrapods.  
 
In zebrafish, a member of the bony-fish family, expression analysis, gene-target knockdown 
experiments, and in vitro catalytic assays indicate that ST8SiaII is the predominant polyST 
(Marx et al., 2007). Unexpectedly, the ST8SiaIV gene seems to be completely lost in some 
members of the bony-fish family like takifugu and tetraodon. These findings might support 
the assumption that early after the evolutionary appearance of polySTs in lower vertebrates, 
ST8SiaIV had no significant function. The high frequency of chromosomal rearrangements 
detected in the region containing ST8SiaIV genes in fish and mammals, may explain the 
divergent evolution of ST8SiaIV compared to the conserved evolution of ST8SiaII in lower 
and higher vertebrates. 
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Objectives 
 
PolySia is a linear and negatively charged homopolymer of a2,8- linked sialic acid residues 
and mainly attached to the neural cell adhesion molecule (NCAM). Due to the large 
hydrodynamic radius of polySia, adhesive properties of NCAM in homo- and heterophilic 
interactions are attenuated. In accordance with these features, polySia has been demonstrated 
to be involved in conferring plasticity to e.g. neuronal tissue. PolySia expression is high 
during embryonic development and reaches a maximum in the perinatal brain. In the adult 
organism polySia expression is highly restricted, but polySia is re-expressed in a number of 
malignant tumors. ST8SiaII is the predominant polyST in developing tissue as well as in 
tumors. Therefore, tumor specific inhibition of ST8SiaII might provide an attractive means in 
cancer therapy.  
Depending on the enzyme (ST8SiaII and IV) and species, polysialyltransferases contain five 
to six N-glycan attachment sites, which, as shown in an earlier study, are all modified with 
core structures. Moreover, two out of the six N-glycans in the murine ST8SiaII are involved 
in the formation of an active enzyme.  
To further explore structure-function relationships in the polysialyltransferases, my work was 
focused on the production of minimally glycosylated and soluble recombinant 
polysialyltransferases. Including ST8SiaII from murine and fish origin, the first goal was to 
determine the minimal active enzyme at linear sequence level. As a second goal the influence 
of individual N-glycans for solubility, activity, and stability of recombinant proteins was 
addressed. For this purpose, recombinant proteins were planed to be comparatively expressed 
in mammalian and insect cells. Ultimately, this study aimed at identifying a way to express 
ST8SiaII in a bacterial system in the absence of N-glycans to generate yields sufficient to 
initiate protein crystallization trials. 
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Chapter 1:  
Characterization of the eukaryotic polysialyltransferase ST8SiaII 
from zebrafish 
 
1.1. Introduction  
 
Carbohydrates that are components of glyco- lipids and –proteins are well known cellular 
communication structures and the passed decade has demonstrated that biosynthetic 
deficiencies in conjunction with the formation of cellular glycoconjugates (summary term for 
glycolipids and glycoproteins) cause severe human diseases (Endo, 2007). Glycosylation 
starts in the endoplasmatic reticulum (ER) and follows the secretory pathway of the 
vertebrate cells (Trombetta, 2003). In particular, the N-glycans of molecules involved in the 
transport of cellular signals like receptors, adhesion molecules and also soluble ligands, have 
been intensively studied (Zhao et al., 2008).  
N-glycosylation of glycoproteins starts in the ER and follows the secretory pathway of the 
cells. In the rough ER, an oligosaccharide precursor (Glc3Man9GlcNAc2) preassembled on 
dolichol-pyrophosphate is transferred onto the asparagine (N) residues located in N-X-S/T 
consensus motifs of nascent polypeptide chains, X thereby is any amino acid except proline. 
Remodelling processes of the precursor glycan, which occur during the transport of the 
glycoconjugate along the secretory pathway generate a diverse set of N-glycans. In the ER 
the protein has to reach the “native conformation” to be allowed to exit and reach the 
subsequent compartment. A chaperon assisted quality control system exists in the ER and 
supports the folding process. Proteins involved in this quality control system are lectins that 
recognize the oligosaccharide precursor after the ER-resistent glucosidases I and II have 
removed two glucose residues (Glc1Man9GlcNAc2). Only properly folded proteins are 
further transported along the secretory pathway (Trombetta, 2003).  
Properties of proteins can be altered by N-glycan addition. A prominent example in this field 
is the neural cell adhesion molecule NCAM, which, due to the addition of polysialic acid 
(polySia) can switch its adhesive into anti-adhesive properties. NCAM is a member of the 
immunoglobuline superfamily (Cunningham et al., 1987; Colley, 2008). The molecule 
contains five immunoglobuline(Ig)- like and two fibronectin type-III(FNIII)- like domains in 
the extracellular part. PolySia, a linear homopolymer of a2,8- linked sialic acid (Sia) 
residues, can be added to N-glycan attachment sites in the fifth Ig- like domain. Due to the 
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high water binding capacity of the negatively charged polymer, a large hydrate shell covers 
the entire NCAM protein surface and by stereochemical means (hindrances and electrostatic 
repulsion) interferes with homophilic and heterophilic interactions of NCAM. Polysialylation 
of NCAM results in an enlarged intermembrane space that leads to a decrease of cell-cell 
interactions (Yang, Yin, and Rutishauser, 1992; Johnson et al., 2005). 
Two enzymes are capable to synthesize polySia in eukaryotes – the polysialyltransferases 
(polySTs) ST8SiaII and ST8SiaIV. Both enzymes have been cloned, sequenced and shown to 
be involved in the polysialylation of NCAM (Eckhardt et al., 1995; Nakayama et al., 1995; 
Scheidegger et al., 1995; Kojima et al., 1995). Both mammalian polySTs belong to the a2,8-
sialyltransferase family. Members of this protein family share three highly conserved amino 
acid motifs: L-motif (large motif), S-motif (short motif) and VS-motif (very short motif). In 
addition, the PSTD-motif (polysialyltransferase domain) has been identified to mark polySTs 
in this family (Harduin-Lepers et al., 2005; Nakata, Zhang, and Troy, 2006).  
Studies carried out to identify the function of conserved motifs showed that the L-motif is 
involved in binding of the donor substrate CMP-Neu5Ac (shown for a2,6-sialyltransferase; 
ST6Gal I), whereas the S-motif participates in binding both CMP-Neu5Ac as well as the 
acceptor protein (Datta and Paulson, 1995; Datta, Sinha, and Paulson, 1998). Mutation of a 
conserved histidine residue in the VS-motifs (very short motif) of ST8SiaII and ST8SiaIV 
resulted in inactive enzymes (Kitazume-Kawaguchi, Kabata, and Arita, 2001). The PSTD-
motif is essential to establish polysialylation capacity as demonstrated by recombinant 
expression of ST8SiaIV variants lacking the PST domain or harboring a truncated PSTD 
(Nakata, Zhang, and Troy, 2006). 
In addition, studies using the thiol-directed alkylating reagents, N-ethylmaleimide and 
iodoacetamide with fractions containing embryonic chick brain polySTs revealed that at least 
one out of six conserved cysteine residues is critical for polysialylation activity (Drickamer, 
1993; Sevigny et al., 1998). Further studies demonstrated that the first cysteine residue (C) 
located in the L-motif and the cysteine of the S-motif form a disulfide bridge, whereas the 
second cysteine in the sialyl-motif L and the cysteine located at the very C-terminus of the 
enzymes form a second disulfide bond (Angata et al., 2001). 
Beside the integrity of the conserved functions described above, N-glycosylation is a 
prerequisite for polyST activity. Previous studies revealed that ST8SiaII and ST8SiaIV 
comprise six and five N-glycosylation attachment sites, respectively. Comprehensive 
mutagenesis studies were applied to determine the influence of each N-glycan on polyST 
activity. These characterizations indicated that ST8SiaII activity depends on the presence of 
   Chapter 1 - Introduction 
 
 18 
N-glycosylation sites N89 and N219, whereas ST8SiaIV requires an N-glycan at position 
N74. Remarkably, the N-glycans at positions N89, N219, and N234 in ST8SiaII as well as 
N50, N74, and N119 in ST8SiaIV are additionally modified by polySia. This modification of 
polySTs by polySia has been referred to as autopolysialylation, although it is not clear yet, 
whether the modification represents an intra- or intermolecular process (Close, Tao, and 
Colley, 2000; Close et al., 2001; Mühlenhoff et al., 2001). 
Interestingly, only a few protein acceptors carrying polySia have been identified until now, 
whereupon NCAM is by far the most prevalent (Rothbard et al., 1982). Additional polySia 
carriers are the a subunit of the voltage dependent sodium channel (Zuber et al., 1992), the 
scavenger receptor CD36, identified as soluble protein in human breast milk (Yabe et al., 
2003) and, as shown in a most recent study, neuropilin-2 expressed on matured dendritic cells 
(Curreli et al., 2007). The selectivity of the polysialylation reaction has recently been 
rationalized by the identification of a polyST recognition site on NCAM. Within the first 
FNIII-like domain of NCAM two structural motifs - an acidic patch and an a-helix - were 
identified as critical for polysialylation efficiency and precise contact formation between 
polyST and NCAM, respectively. The precision of protein-protein interaction between 
NCAM and polyST has been suggested to be needed also for the correct presentation of the 
N-glycans localized in the Ig5 domain (Mendiratta et al., 2005; Mendiratta et al., 2006; 
Colley, 2008).  
These latter results may also explain the observed drop in activity if polySTs were tested with 
free sugar acceptors (Angata et al., 2000). Nonetheless, initiation of polysialylation on 
protein free monosialyl (Neu5Aca(2,3)-Galß(1,4)-R ) and disialyl acceptors (Neu5Aca(2,8)-
Neu5Aca(2,3)-Galß(1,4)-R) was observed (Angata et al., 2000; Angata, Suzuki, and Fukuda, 
2002).  
Since the cloning in 1995 significant effort has been made to gain insight into the catalytic 
mechanism of polySTs, however, all these studies were drastically hampered by the 
availability of recombinant enzymes. Logically, information on the 3D-structure of polySTs 
is completely missing. Since N-glycosylation and disulfide bonds are important for the 
formation of active polySTs, expression systems have so far been limited to eukaryotic cells 
(CHO, COS, and insect cells), resulting in only very small protein yields for the recombinant 
mammalian polySTs (Mühlenhoff et al., 2001; Angata et al., 2001).  
Interestingly, the homologous enzyme from the lower vertebrate zebrafish (zST8SiaII) lacks 
one out of six N-glycosylation sites, whereupon a functional enzyme is maintained (Marx et 
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al., 2007). Therefore, we speculated that zST8SiaII is a suitable candidate for a purification 
approach.  
The first goal of my study was to optimize the conditions for recombinant expression of 
zST8SiaII, by identifying the minimally active enzyme at the linear sequence level with 
respect to the number of functionally important N-glycosylation sites. Furthermore large scale 
production using a baculoviral expression system was established and finally enabled the 
preparation of an active eukaryotic polyST in good yield and high purity. Using saturation-
transfer-difference (STD)-NMR spectroscopy we gained first insight into substrate binding 
properties of eukaryotic polySTs. 
 
 
1.2. Experimental Procedures 
 
1.2.1. Materials 
Endoneuraminidase NF (endoNF) was purified from Escherichia coli K1 bacteriophage as 
described previously (Gerardy-Schahn et al., 1995).  Recombinant soluble proteinA-NCAM 
was expressed in CHO-2A10 cells and purified as described in Mühlenhoff et al. (1996). The 
eukaryotic expression vector pPROTA (Sanchez-Lopez et al., 1988) was kindly provided by 
Dr. R. Beathnach (INSERM, Nantes, France). Oligosaccharide acceptors and CMP-Neu5Ac 
were purchased from Nakalai. Neu5Acß2Me and Neu5Aca2Me were generously provided by 
Prof. Dr. Mark von Itzstein (Griffith University, Gold Coast, Australia). 
1.2.2. Expression Plasmids  
To construct N-terminally truncated zST8SiaII variants for expression in (CHO)-cells, 
ST8SiaII from zebrafish (genbank accession number NP_705948) was amplified from the 
plasmid of full length, N-terminally Flag-HA tagged zST8SiaII (pFlagHA-ST8SiaII; Marx et 
al., 2007) using the following primer pairs: 
N?26: GCATGAATTCGGAAGTGGAGGAAGAA / reverse primer: CGTAGAATTCATG 
TAGGAGGTTTGCA 
N?54: GCATGAATTCGGATCTGAATGCTGCCCC / reverse primer: CGTAGAATTCAT 
GTAGGAGGTTTGCA 
N?86: GCATGAATTCGGCTTCATCCTCATCTGAATGG / reverse primer: CGTAGAAT 
TCATGTAGGAGGTTTGCA 
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N?95: GCATGAATTCGAGAACCTTGTCTAACCTC / reverse primer: CGTAGAATTCA 
TGTAGGAGGTTTGCA 
PCR products were digested with EcoRI and after gel purification (Qiagen) ligated into the 
corresponding restriction site of pProtA, a cell culture vector containing a transin secretion 
signal sequence and the sequence encoding IgG binding domain of Staphylococcus aureus 
proteinA. The resulting plasmids drive the expression of N-terminally proteinA-fusion 
proteins. The identity of all constructs was confirmed by sequencing. 
To construct N-terminally truncated zST8SiaII variants for expression in insect cells, 
ST8SiaII from zebrafish was amplified from the plasmid pFlagHA-ST8SiaII using the primer 
pairs: 
N?26: CGGCTCATGACGGAAGTGGAGGAAGAAATCGC / reverse primer: CGGAAGC 
TTTTATGTAGGAGGTTTGCATGGTC 
N?86: CGGCTCATGACGTCATCCTCATCTGAATGGAC / reverse primer CGGAAGCTT 
TTATGTAGGAGGTTTGCATGGTC 
PCR products were digested with BspHI and HindIII, gel purified (Qiagen) and ligated into 
the restriction sites NcoI and HindIII of a modified pFastbac1 vector (Invitrogen) containing 
a honeybee melittin (HBM) secretion signal and a N-terminal His-tag. The resulting plasmids 
express an N-terminal His-tagged protein. The identity of all constructs was confirmed by 
sequencing. 
1.2.3. Site-directed mutagenesis of ST8SiaII cDNA  
N-glycosylation site deficient zST8Sia II variants were generated by PCR using the 
QuikChange site-directed mutagenesis kit (Stratagene) following the manufactures 
guidelines. N-glycosylation sites were destroyed by substituting the asparagine (N) in the N-
X-S/T motifs by glutamine (Q). For site directed mutagenesis the plasmid pFlagHA-ST8SiaII 
was used as template. The primer pairs used are listed below (point mutations are in bold): 
N95Qs:CTCATCTGAATGGACTTTCCAAAGAACCTTGTCTAACCTC 
N95Qas:GAGGTTAGACAAGGTTCTTTGGAAAGTCCATTCAGATGAG 
N140Qs:GACCGTCAGAGCACCACACAAATCTCAGAGAATCTGTAC 
N140Qas:GTACAGATTCTCTGAGATTTGTGTGGTGCTCTGACGG 
N174Qs:GAACTCTGGCATACTACTGCAGAGCAGCTGCGGCAGAGAG 
N174Qas:CTCTCTGCCGCAGCTGCTCTGCAGTAGTATGCCAGAGTTC 
PCR products were subcloned into EcoRI and BstXI sites of pFlagHA-ST8SiaII and the 
identity of all constructs was confirmed by sequencing. To generate double or triple variants 
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in terms of N-glycosylation sites, the corresponding mono or double variants were used as 
templates in an additional site-directed mutagenesis approach. 
To obtain the corresponding ProtA-fusion proteins, the Flag-HA-ST8SiaII variants were used 
as template using the primer pairs described above. 
1.2.4. Cultivation of CHO cells 
PolySia negative Chinese hamster ovary (CHO)-2A10 cells, defective in the ST8SiaIV gene 
(Eckhardt et al., 1995), were kept in a humidified incubator at 37°C and 5 % CO2. Cells were 
cultured in DMEM/HAM’s F12 medium (Biochrom) supplemented with 5 % fetal calf serum 
(biochrom) and 1 mM sodium pyruvate (Gibco BRL). Confluent cell layers were treated with 
PBS/EDTA to detach the cells from culture vessel and diluted 1:20 in fresh medium. 
For long term storage in liquid nitrogen, cells were pelleted by centrifugation (5 min, 200xg, 
RT) and resuspended in culture medium containing 20 % fetal calf serum and 10 % DMSO at 
a concentration of 1x107 cells/ml. Aliquots of 1 ml were filled in cryo vials, stored overnight 
at -80°C and then transferred to liquid nitrogen. 
To recover frozen cell pellets, they were kept on dry ice for 5 min, thawed in a water bath at 
37°C and diluted by drop wise addition of culture medium containing 10 % fetal calf serum. 
After centrifugation (5 min, 200xg, RT) the cell pellet was again resuspended in culture 
medium containing 10 % fetal calf serum and transferred to culture vessels. 
1.2.5. Transfection of CHO cells 
For transient transfection of CHO cells 1.9x106 cells were seeded in 100 mm culture vessels 
and cultivated over night as described in 1.2.4. A transfection mix was prepared by diluting 
4 µg plasmid DNA and 24 µl Lipofectamine (Invitrogen) in 400 µl OptiMEM (Gibco BRL) 
each. Both dilutions were combined and incubated for 30 min at RT. 
The CHO cell layer (70-80 % confluent) was washed twice in PBS and incubated with 
freshly prepared transfection mix diluted in 3.2 ml OptiMEM for 5-6 h. The transfection was 
stopped by replacement of the transfection mix with 8 ml culture medium. Cells were 
cultivated for additional 72 h. 
For immunofluorescence staining 0.9x105 cells were seeded per well of a six well tissue 
culture plate, containing coverslips. The transfection procedure was performed as described 
above, using 1 µg DNA and 6 µl Lipofectamin diluted in 100 µl OptiMEM each. The total 
volume of the prepared transfection mix was 1 ml per well of a six well tissue culture plate. 
After 5-6 h, transfection mix was replaced by 2.5 ml fresh culture medium and cells were 
incubated for another 48 h as described in 1.2.4. 
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1.2.6. Cultivation of Sf9 cells 
Suspension cultures of Spodoptera frugiperda (SF9) cells were cultivated at 27°C and 90 rpm 
in protein free Insect XPress-medium (BioWhittaker). Cell density was maintained between 
0.5x106 and 5x106 cells per millilitre by diluting dense cultures in fresh medium. 
For long term storage in liquid nitrogen, cells were pelleted by centrifugation (5 min, 200xg, 
RT) and resuspended in the conditioned culture medium containing 10 % DMSO at a 
concentration of 2x107 cells/ml. Aliquots of 1 ml were filled in cyro vials and cooled down 
by subsequent incubations at 4°C and -20°C for 1 h each. Cells were stored overnight at  
-80°C and then transferred to liquid nitrogen. 
To recover frozen cell pellets, they were kept on dry ice for 5 min, thawed in a water bath at 
37°C and directly added to 30 ml culture medium in a culture vessel. 
1.2.7. In vitro assay for Auto- and NCAM polysialylation 
PolySia negative CHO-2A10 cells, defective in the ST8SiaIV gene (Eckhardt et al., 1995), 
were transfected as described in 1.2.5. To standardize the concentration of ProtA-zST8SiaII 
variants for the polysialylation assay, an enzyme-linked immunosorbent assay (ELISA) was 
used as described in Mühlenhoff et al. (2001).  
Round-bottom microtiter plates (Greiner) were coated overnight with 0.2 µg murine IgG 
(Pierce) at 4°C and blocked with bovine serum albumin (1 % in PBS) (Sigma) for 2 h at RT. 
Plates were washed with PBS prior to addition of 20 µl/well of cell supernatant that contained 
ProtA-zST8SiaII variants. Plates were incubated for 1 h at RT to allow binding of ProtA–
polyST fusion variants to IgG. In parallel, serial dilutions (1 - 0.05 ng/ml) of the recombinant 
IgG-binding fragment of ProteinA (Sigma) were included to generate a standard curve. After 
the adsorption step, plates were washed three times with PBS, before adding 20 µl/well of 
biotinylated anti-ProteinA antibody in a 1:80,000 dilution (Sigma). The plates were incubated 
for 1 h at 37°C and washed three times with PBS. The bound biotinylated antibody was 
detected with streptavidin-horseradish peroxidase conjugate (Roche) using 20 µl/well of an 
1:20,000 dilution. After 30 min at 37°C plates were washed three times with PBS and 
developed with 50 µl/well of substrate solution containing 5 µg 3,3’,5,5’-
tetramethylbenzidine (TMB), 100 mM sodium acetate, 100 mM citric acid, and 0.0045 % 
H2O2. The staining reaction was stopped after 20 min by adding 25 µl/well 2 N H2SO4, and 
the optical density at 450 nm was determined using a PowerWave 340 microtiter plate 
spectrophotometer (BioTek). All samples were measured in serial dilutions, and triple values 
were analyzed for each dilution. 
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Subsequently, polyST activity was assayed by incorporation of [14C]-labeled sialic acid 
residues into a growing polySia chain and monitored by SDS-PAGE followed by 
autoradiography. 1 µg of each enzyme variant was incubated with 20 µl IgG-coated 
sepharose beads (Pierce) for 1 h at 4 °C in a head-over-head shaker, to allow adsorption of 
the proteinA-tagged polyST variants to the beads. Afterwards the beads were washed three 
times with 1 ml PBS and two times with 1 ml reaction buffer (10 mM sodium cacodylate 
buffer or MES pH 6.7; 10 mM MnCl2) before resuspended in 40 µl reaction buffer containing 
0.12 mM (21 Bq/µl) [14C]-CMP-Neu5Ac (GE Healthcare). Samples were incubated at 27°C 
and 1300 rpm to allow enzyme reaction. After 4 h reactions were terminated by washing the 
beads two times with 1 ml PBS. As an assay control, one out of two parallel samples was 
treated with 20 µg/ml of the polySia-degrading enzyme EndoNF in a final volume of 50 µl 
PBS for 30 min at 37°C. After two additional washing steps with 1 ml PBS each, residual 
buffer was removed and 20 µl of 2xLaemmli loading buffer containing 2 % ß-
mercaptoethanol were added. Samples were heated for 10 min at 60°C and analyzed by SDS-
PAGE followed by autoradiography (Mühlenhoff et al., 2001). To investigate NCAM-
polysialylation, cell culture supernatant containing 30 ng of recombinant polySia-free ProtA-
NCAM was additionally adsorbed to IgG-coated sepharose beads and the assay was 
performed as described above. 
1.2.8. Immunofluorescence of zST8SiaII variants in CHO 2A10 cells 
48 h after transfection(1.2.5), cells were washed with PBS, fixed in 4 % paraformaldehyde 
for 20 min, and washed two times with PBS. Coverslips were blocked in 20 % horse serum in 
PBS for 30 min. Subsequently, polySia staining was performed with 5 µg/ml of primary 
monoclonal antibody 735 (Behring Werke Marburg) in 20 % horse serum. After washing 
three times with PBS, the cells were incubated for 30 min at RT with sheep anti-mouse IgG-
Cy3 (1:300; Sigma) in 20 % horse serum. For intracelullar Flag-staining, cells were 
permeabilized in 0.2 % triton X100 in PBS for 9 min and stained with anti-Flag M5 (Sigma). 
After washing three times with PBS, the cells were incubated for 30 min with sheep anti-
mouse IgG-Cy3 in 20 % horse serum.  
The cells were washed three times with PBS, and coverslips were mounted in vectashield 
(Vectashield) and analyzed under an Axiovert 200 M fluorescence microscope (Zeiss). 
1.2.9. zST8SiaII expression and purification from insect cells 
Recombinant baculoviruses were generated based on transposon-mediated recombination in 
E. coli DH10Bac cells using the Bac-to-Bac Baculovirus Expression System (Invitrogen). 
   Chapter 1 – Experimental Procedures 
 
 24 
Preparation of recombinant bacmid DNA: 
100 µl of competent E. coli DH10Bac were thawed on ice and incubated for 30 min with 
20 ng of the respective pFastBac vector construct. The transformation mix was subjected to a 
heat shock at 42°C for 45 sec and incubated on ice for 2 min. 900 µl of SOC-medium were 
added, the cell suspension was incubated at 37°C for 4 h before plated on selective LB-agar 
plates containing 50 µg/ml kanamycin, 7 µg/ml gentamicin, 10 µg/ml tetracycline and 
40 µg/ml IPTG. For blue-white screening 30 µl of X-Gal solution (20 mg/ml in DMSO) were 
spread on the plates prior to plating. Positive transformants were identified after 48 h 
incubation at 37°C as pure white colonies and re-streaked on fresh plates to confirm the 
phenotype. 5 ml LB-medium containing 50 µg/ml kanamycin, 7 µg/ml gentamicin and 
10 µg/ml tetracycline were inoculated with a positive colony and incubated overnight at 37°C 
and 300 rpm. Bacmid DNA was isolated using the “Concert High Purity Plasmid Purification 
System” (GibcoBRL) according to the manufactures instructions. 3 ml of bacterial culture 
were pelleted (1 min, 12,000xg, RT), resuspended in 400 µl buffer E1 and lysed for 5 min at 
RT after addition of 400 µl buffer E2. 400 µl neutralization buffer E3 was added, the samples 
were centrifuged (10 min, 12,000xg, RT) and the supernatant was applied to the concert HP 
columns, equilibrated in buffer E4. After washing two times with 2.5 ml buffer E5, bound 
bacmid DNA was eluted in 900 µl buffer E6. 630 µl of 2-propanol were added to the eluent 
and the DNA was pelleted (30 min, 20,000xg, 4°C). The pellet was washed with 1 ml of 70% 
ethanol and centrifugated (15 min, 20000xg, 4°C). The bacmid DNA was air-dried for 30 min 
and resolved in 50 µl of 5 mM Tris/HCl pH 8 for 2 h at RT and stored at 4°C.  
Production of recombinant baculoviruses and high-titer stocks: 
Baculoviruses were produced by trans fecting the prepared recombinant bacmid DNA into Sf9 
cells. For transient transfection 1x106 cells were seeded per well of a six well tissue culture 
plate. Transfection mix was prepared from 5 µl of bacmid DNA and 6 µl Cellfectin 
(Invitrogen) in 100 µl of culture media each. Both dilutions were combined and incubated for 
30 min at RT. The medium was aspirated from adherend Sf9 cells and replaced with 
transfection mix diluted in 1 ml culture medium. The transfection mix was removed after 
14 h and replaced with 2 ml culture medium. The transfected cells were incubated at 27°C for 
4-7 days until signs of viral infection like enlarged cell diameters and a granular appearance 
of the cells were clearly visible. 
The supernatant (low-titer P1-stock) was harvested and stored at -80°C. For virus 
amplification 40 µl P1-stock were added to 4 ml Sf9 cells (2x106 cells) in a 25 cm2 cell 
culture bottle (Sarsted) and incubated for 3-4 days (P2-stock). Further amplification of the 
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baculovirus stock was performed by infecting 50 ml suspension culture (2x106 cells/ml) with 
50 µl of P2-stock. After three days, the cells were pelleted by centrifugation (5 min, 300xg, 
RT) and the supernatant was sterile filtered (0.2 µm cellulose acetate filter; Sartorius) and 
stored at 4°C (P3-stock).  
Baculoviral expression of ST8SiaII variants in Sf9 cells: 
For baculoviral expression of recombinant zST8SiaII variants log-phase Sf9 cells at a density 
of 1.5-2x106 cells/ml were infected with different concentrations of P3-stock and cultivated 
for time response at 27 °C and 90 rpm. Culture supernatants were assayed for protein 
expression by SDS-PAGE followed by western blot analysis (1.2.11). 
The dose of baculovirus required for optimal expression of recombinant protein was used for 
subsequent large scale expressions cultures. 
Purification of baculoviral expressed zST8SiaII variants from Sf9 cells: 
4 L-expression cultures were infected with the optimal baculovirus concentration and 
harvested at the time point determined previously. To harvest the recombinantly expressed 
protein, cells were pelleted (10 min, 300xg, 4°C) and the supernatant was adjusted with 
NaOH to pH 7.5 and re-centrifugated (20 min, 7,000xg, 4°C). Subsequently, the supernatant 
was filtered (0.22 µM Millipore-1L-device) and concentrated to 100 ml (Ultrasette 
10,000 MWCO) at 4 °C. To remove low molecular weight inhibitors the concentrate was 
diluted 1:5 with buffer DT (50 mM Tris/HCl; 100 mM NaCl; pH 7.5) and concentrated to 
80 ml. Protein containing solution was filtered (0.22 µM) and 10 % glycerol was added. 
Coupling to Ni2+chelating matrix (Probond-resin; Invitrogen) was performed overnight at 
4°C. For all following steps Äkta FPLC (GE Healthcare) was used with a flow rate of 
1 ml/min. The protein was eluted stepwise starting with 10 mM imidazole in precooled 
buffer A (50 mM Tris/HCl pH 7.5; 100 mM NaCl; 10 % glycerol) followed by 100 mM 
imidazole and 400 mM imidazole in buffer A, respectively. 1 ml fractions were collected and 
protein containing fractions were analyzed with SDS-PAGE followed by western blot 
analysis and silver staining (1.2.11/12). Polysialyltransferase containing fractions were 
concentrated in a vivaspin concentrator (10,000 MVCO PES; Vivascience), quick-frozen in 
liquid nitrogen and stored at –80°C or further analyzed by size-exclusion chromatography. 
1.2.10. Size-exclusion chromatography 
A Superdex 200 HR 10/30 column (Amersham Biosciences) was equilibrated in degassed 
and 0.22 µm sterile filtrated buffer DT2 (10 mM Tris/HCl pH 7.5;150 mM NaCl) using the 
Äkta FPLC sys tem (GE Healthcare). Purified protein was applied and eluted in 0.5 ml 
fractions at a flow rate of 0.5 ml/min. Protein standards were applied under the same 
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conditions to generate a molecular weight standard curve. Polysialyltransferase containing 
fractions were concentrated in a vivaspin concentrator (10,000 MVCO PES; Vivascience) 
and stored at -80°C after quick-freezing in liquid nitrogen. 
1.2.11. SDS-PAGE analysis and immunoblotting 
For protein separation a SDS-PAGE was performed according to Laemmli (Laemmli, 
Beguin, and Gujer-Kellenberger, 1970). SDS-PAGE gels were composed of a 3 % stacking 
gel [125 mM Tris/HCl pH 6.8; 0.1 % SDS; 3 % polyacrylamide(40 % 4 K-Mix, AppliChem)] 
and a separating gel in a range of 7-14 % polyacrylamide [375 mM Tris/HCl pH 8.8; 0.1 % 
SDS; 7-14 % Acrylamide (40 % 4 K-Mix, AppliChem)]. After mixing all components 
polymerization was initiated by adding 0.1 % TEMED and 1 % ammonium persulphate. 
For sample preparation, the samples were diluted 1:1 with Laemmli buffer containing 2 % ß-
mercaptoethanol and boiled for 5 min or heated to 60°C for 10 min, if they contained heat-
sensitive polySia.  
Electrophoresis was performed in SDS-electrophoresis buffer (50 mM Tris; 350 mM glycine; 
0.1 % SDS) at 60 V for the stacking gel and at 140 V for the separating gel. 
After SDS-PAGE, separated proteins were transferred onto a nitrocellulose membrane 
(Schleicher & Schüll), using a semidry blotting chamber (Biometra) at 2 mA/cm2 for 45 min. 
Gel and membrane were placed between two layers of filter paper (Whatman) soaked in 
blotting buffer (48 mM Tris, 39 mM glycine). Western blots were developed using the 
recommended primary antibody concentration, followed by anti-mouse alkaline phosphatase 
conjugate (Dianova). Nitro blue tetrazolium (NBT) and 5-bromo-4-chloro-3- inodyl 
phosphate (BCIP) were used as substrates for alkaline phosphatase staining reaction. 
1.2.12. Silver staining  
After SDS-PAGE, protein bands were visualized by silver staining. Initially, the SDS-gel was 
incubated in fixation solution (10 % acetic acid; 30 % ethanol; 1.85 % formaldehyde) for 
20 min. After washing three times with 50 % ethanol for 20 min the gel was incubated for 
exactly 1 min in thiosulphate solution (20 mg thiosulphate in 20 ml H2O) and washed in 
deionised water for 40 seconds. Subsequently the gel was incubated in silver staining solution 
(0.2 % AgNO3; 2.8 % formaldehyde) for 20 min. After washing with deionised water the gel 
was incubated in developing solution (6 % NaCO3; 2 % (v/v) thiosulphate solution; 1.85 % 
formaldehyde) until the bands appeared. Staining was stopped by washing with water and 
stop solution (10 % acetic acid; 30 % ethanol). Before drying, the gel was incubated in 30 % 
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ethanol for 30 min and subsequently in drying solution (10 % glycerol; 20 % ethanol) for 
20 min. Gels were dried in cellophane foil overnight at 50 °C. 
1.2.13. Soluble radioactive activity assay for polyST 
To monitor the enzymatic activity of polyST in solution, purified zST8SiaII?N86 was 
incubated with a mixture of radiocarbon labeled CMP-Neu5Ac (860 Bq, Amersham 
Pharmacia Biotech), unlabeled CMP-Neu5Ac (0.25 mM) and purified NCAM in reaction 
buffer (10 mM sodium cacodylate buffer pH 6.7; 10 mM MnCl2) for 3 h at 26 °C and 
1300 rpm. Afterwards 2xLaemmli buffer containing 2 % ß-mercaptoethanol was added in a 
1:1 ratio and half of the sample was incubated with 1 µl of 1 mg/ml EndoNF for 30 min and 
1300 rpm at 37 °C. Samples were heated at 60 °C for 10 min and separated on a 7.5% SDS-
gel followed by autoradiography.  
1.2.14. Enzyme-linked immunosorbent assay for polysialyltransferase activity 
To monitor polyST activity in a non radioactive test system an enzyme-linked 
immunosorbent assay (ELISA) was established by Dr. Stummeyer from our laboratory. A 96 
well microtiter plate (Greiner) was coated with 25 µl/well of 10 µg/ml mouse IgG (Pierce) in 
PBS for 3 h at RT. After washing three times with PBS plastic surface was blocked with 1 % 
BSA in PBS (Sigma) overnight at 4°C. For NCAM-polysialylation 25 µl of 30 ng/ml polySia 
free proteinA-NCAM fusion protein was adsorbed for 1 h at RT. After washing three times 
with PBS and two times with reaction buffer (10 mM sodium cacodylate buffer pH 6.7; 
10 mM MnCl2, 3.3% human serum) 0.2 µg polyST were directly incubated in reaction buffer, 
containing 1 mM CMP-Neu5Ac for 3 h at 27°C or overnight at RT. The plates were washed 
two times with PBS and subsequently incubated with 25 µl/well of biotinylated fab-
fragments of mAb 735 (Davids Biotechnologie) diluted 1:500 in 1 % BSA (Sigma) for 1 h at 
RT. Afterwards, plates were washed three times with PBS. The bound biotinylated antibody 
was detected with streptavidin-horseradish peroxidase conjugate (Roche) using 20 µl of a 
1:20,000 dilution per well. After 30 min at 37°C plates were washed three times with PBS 
and developed with 50 µl of substrate solution containing 5 µg 3,3’,5,5’-tetramethylbenzidine 
(TMB), 100 mM sodium acetate, 100 mM citric acid, and 0.0045 % H2O2. Reactions were 
stopped after 20 min by adding 25 µl 2 N  H2SO4, and the optical density at 450 nm was 
measured in PowerWave 340 microtiter plate spectrophotometer (BioTek).  
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1.2.15. Nuclear magnetic resonance (NMR) spectroscopy 
All NMR spectroscopy experiments were performed on a Bruker Avance DRX 600 MHz 
spectrometer using a cryoprobe equipped with triple axis gradient at 283 K in deuterated 
buffer (10 mM Trisd5/DCl, 1 mM MgCl2, pH 6.8).  
ST8SiaII?N86 samples were buffer exchanged using BioSpin 30 columns (BioRad) to 
deuterated 10 mM Trisd5/DCl, 1 mM MgCl2, pH 6.8.  
 
1.2.16. Saturation-transfer-difference-(STD)-NMR spectroscopy 
For STD-NMR spectroscopy (Mayer and Meyer, 2000) purified ST8SiaII was saturated on-
resonance at 0.7 ppm. The off-resonance frequency was set to 40 ppm. A cascade of 
40 selective Gaussian-shaped pulses of 50 ms duration with a 100 µs delay between each 
pulse were used in all STD-NMR experiments to saturate the protein for 2 s. For STD-NMR 
experiments, 13.5 µM recombinant ST8SiaII?N86 was used. All investigated ligands were 
added at a molecular ratio (protein:ligand) of 1:100. A total of 1024 transient experiments 
were acquired, and a WATERGATE sequence was used to suppress the residual HDO signal. 
A spin lock filter with a strength of 5 kHz and a duration of 10 ms was applied to suppress 
residual protein background signals. 
 
1.2.17. 1H-NMR spectroscopy based enzyme assay  
All 1H-NMR spectroscopy experiments were performed using 13.5 µM purified 
ST8SiaII?N86 and 1.35 mM CMP-Neu5Ac. All investigated substrates were added at a 
molecular ratio (protein:substrate) of 1:100. In a typical 1H-NMR spectroscopy experiment, a 
spectrum containing the enzyme and the acceptor was acquired at t= 0 min. After addition of 
1.35 mM CMP-Neu5Ac, 1H-NMR spectroscopy spectra were recorded in 10 min time 
intervals over 2.5-5 h at 283 K or after overnight incubation at 293 K. A total of 8 transient 
experiments were acquired, and suppression of residual HDO signal was achieved by 
presaturation using a weak radio frequency field for 1.5 s during the relaxation delay. Data 
acquisition and processing were performed with Topspin software (Bruker). Fourier 
transformation, phase correction and base line correction were performed for all 1H-NMR 
spectroscopy experiments. 
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1.2.18. Crystallization trials carried out with ST8SiaII 
Crystallization trials were accomplished as sitting drop vapor diffusion experiments. Purified 
zST8SiaII?N86 was concentrated to 5.7 mg/ml in 10 mM Tris/HCl pH 7.5; 10 mM MnCl2; 
150 mM NaCl. Crystallization trials were performed in the presence or absence of the donor  
analogue CMP-Neu5Ac-3F (f.c. 2 mM) in our laboratory and at the HT-crystallization 
facility of EMBL; Hamburg (Mueller-Dieckmann, 2006). 
 
 
 
 
1.3. Results  
 
1.3.1. Comparison of zebrafish and murine ST8SiaII on primary sequence level  
 
The polysialyltransferase (polyST) ST8SiaII from zebrafish (zST8SiaII) belongs to the a2,8-
sialyltransferase protein family and therefore contains the L-,S- and VS-motif, respectively, 
that are highly conserved among family members. An alignment of murine and zebrafish 
enzymes revealed 61 % identity on the primary sequence level. Apart from the N-terminus 
these enzymes are highly conserved among the catalytic domain starting at amino acid 88 
(71 % identity), as shown in figure 6 A. The positioning of predicted N-glycosylation sites of 
zebrafish and murine ST8SiaII is depicted in figure 6 B. Interestingly only five N-
glycosylation attachment sites were predicted for the zST8SiaII whereas the murine 
homologue harbors six sites. Enzymatic activity of the murine enzyme crucially depends on 
the presence of the N-glycosylation attachment sites N89 (#3) and N219 (#5) (Mühlenhoff et 
al., 2001; Close et al., 2001).  
As shown by the sequence alignment in figure 6 A the asparagine residue N95 (#3) of 
zST8SiaII corresponds to the important residue N89 (#3) of the murine enzyme. By contrast, 
no asparagine residue is located in a position equivalent to the N-glycosylation site N219 (#5) 
of the murine enzyme. 
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Further comparison revealed that zST8SiaII has a predicted N-glycosylation site in the 
conserved L-motif, which is unique among all polySTs characterized so far. 
 
 
 
Figure 6: Comparison of eukaryotic ST8SiaII from zebrafish and mouse. A. Multiple sequence 
alignment of murine and bonefish ST8SiaII generated with MultAlin (Corpet, 1988). Sequence 
identity is highlighted in dark boxes and sialyl motifs (L, S and VS) as well as the polyST domain 
(PSTD), the transmembrane domain (TMD) and the stem region (stem) are indicated. B. Schematic 
representation of mouse and zebrafish polySTs. Positioning of N-glycosylation sites are given by the 
respective asparagine residues. Sialyl motifs (L, S and VS), polyST domain (PSTD) and conserved 
cysteine residues (C) are indicated. For the murine ST8SiaII N-glycosylation attachment sites required 
for polyST activity are marked by an asterisk.  
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1.3.2. N-terminal truncation of zebrafish ST8SiaII  
 
In order to determine the minimal catalytic domain of zST8SiaII, a set of N-terminally 
truncated enzyme variants was generated. Enzymes lacking 26 (zST8SiaIIDN26), 54 
(zST8SiaIIDN54), 86 (zST8SiaIIDN86) and 95 (zST8SiaIIDN95) amino acids from their N-
terminus were transiently expressed as secreted proteinA fusion constructs in CHO-2A10 
cells. Enzyme activity was assayed essentially as described by Mühlenhoff and coworkers 
(Mühlenhoff et al., 2001). Briefly, enzyme contents of the culture supernatants were 
determined by ELISA directed against the proteinA fusion tag. 1 µg of each enzyme was 
immobilized on IgG-Sepharose beads and incubated with radiocarbon labeled CMP-
[14C]Neu5Ac in the presence or absence of proteinA-NCAM. Samples were separated by 
SDS-PAGE before and after treatment with the polySia-degrading enzyme 
endoneuraminidaseF (endoNF) and reaction products were visualized by autoradiography. 
Polysialylation activity is indicated by a broad radioactive smear removable by endoNF 
treatment. Due to the fact that endoNF does not degrade the last three sialic acid residues of a 
polySia chain, protein acceptors are visualized by the remaining  [14C]-labeled sialic acid 
residues. As depicted in figure 7, N-terminal truncation of up to 86 amino acids retained an 
autopolysialylation and NCAM-polysialylation competent enzyme. However, 
autopolysialylation activity of the D54 and D86 variants appears to be decreased when 
compared to the D26 truncation that lacks only the transmembrane domain. By contrast, N-
terminal truncation of 95 amino acids resulted in a complete loss of activity (fig. 7). Loading 
control by western blot analysis revealed that all enzyme variants were bound to the 
sepharose beads in comparable levels (fig. 7 C). 
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1.3.3. N-glycosylation site N95 is important for polysialylation activity  
 
Analysis of the N-terminally truncated enzyme variants described above revealed, that the 
first two N-glycosylation sites are of minor importance for zST8SiaII activity, because 
zST8SiaII?N86 lacking these sites was found to be active (fig. 7). To investigate the impact 
of the remaining three N-glycosylation sites of zST8SiaII?N86, a comprehensive site-
directed mutagenesis approach was performed. Therefore, the respective asparagine residues 
(N) of the three N-X-S/T motifs were exchanged by glutamine in all possible combinations. 
The polysialylation ability of the resulting enzyme variants was analyzed as described in 
1.3.2. All zST8SiaII?N86 glycosylation variants lacking the third N-glycosylation site N95 
(?3) displayed drastically reduced activity in terms of NCAM-polysialylation as well as 
autopolysialylation (fig. 8 A and B). By contrast, the loss of N-glycosylation sites N140 (?4) 
and N174 (?5) revealed no significant effect with regard to polysialylation activity as all 
affected variants maintained activity. Remarkably, all identified potential N-glycosylation 
sites were found glycosylated, visible as a shift in molecular mass (fig. 7 C). Western blot 
analysis demonstrates tha t all analyzed zST8SiaII?N86 variants were secreted into the cell 
Figure 7: Polysialylation activity of N-terminal 
truncations of zebrafish ST8SiaII. Wild-type and 
N-terminally truncated variants of zST8SiaII were 
transiently expressed as secreted proteinA fusion 
constructs in CHO-2A10 cells. 72 h post transfection 
1 µg of wild type or truncated zST8SiaII were 
adsorbed to IgG-Sepharose and used to analyze auto- 
and NCAM-polysialylation in vitro. A. For 
autopolysialylation proteinA-ST8SiaII variants bound 
to Sepharose-beads were incubated for 4 h at 37 °C in 
the presence of 0.12 mM CMP-[14C]-Neu5Ac. 
Samples were separated by 10 % SDS-PAGE before 
(-) and after (+) treatment with EndoneuraminidaseF 
(EndoNF) and visualized by autoradiography. B. For 
NCAM-polysialylation samples were treated as 
described above, but additionally, 36 ng proteinA 
fused NCAM were adsorbed to the Sepharose-beads. 
The reaction mixture was analyzed by 7 % SDS-
PAGE. C. Control of Sepharose-beads for 
comparable loading with proteinA (ProtA)-ST8SiaII 
variants by western blot analysis. Samples were 
analyzed by 10 % SDS-PAGE followed by western 
blotting using an antibody directed against the 
proteinA part. 
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culture supernatant. However, expression levels were analysed by proteinA-ELISA and found 
to be significantly reduced for all inactive enzyme variants lacking the third N-glycosylation 
site (up to fourfold for ProtA-zST8SiaII?3?4?5) as well as for the still active double mutant 
ProtA-zST8SiaII?4?5 (data not shown).  
 
 
 
Figure 8: Polysialylation activity of N-glycosylation depletion variants of zebrafish 
ST8SiaII?N86. N-glycosylation variants of N-terminally truncated zST8SiaII?N86 were transiently 
expressed as proteinA fusion constructs in CHO-2A10 cells. 72 h after transfection 1 µg of each 
enzyme were adsorbed to IgG-Sepharose and used to analyze auto- and NCAM-polysialylation in 
vitro. A. For autopolysialylation Sepharose-fixed proteinA-ST8SiaII variants were incubated for 4 h at 
37 °C in the presence of 0.12 mM CMP-[14C]-Neu5Ac. Samples were separated by 10 % SDS-PAGE 
before (-) and after (+) treatment with EndoneuraminidaseF (EndoNF) and visualized by 
autoradiography. B. For NCAM-polysialylation samples were treated as described above, but 
additionally, 36 ng proteinA fused NCAM were adsorbed to Sepharose-fixed proteinA-ST8SiaII 
variants. The reaction mixture was analyzed by 7 % SDS-PAGE. C. Western blot analysis of 1 µg 
Sepharose immobilized proteinA-ST8SiaII variants. Samples were analyzed by 10 % SDS-PAGE 
followed by western blotting using an antibody directed against the proteinA part. 
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Taken together the mutagenesis study revealed tha t (i) all predicted N-glycosylation sites are 
glycosylated and that (ii) the presence of N-glycosylation site N95 is required and sufficient 
for zST8SiaII?N86 activity. This is an important difference to murine ST8SiaII, where two 
N-glycans were found to be required for in vitro activity (Mühlenhoff et al., 2001). 
 
 
 
1.3.4. Enzymatic activity of zST8SiaII variants in vivo  
 
So far the crucial impact of N-glycosylation site N95 (#3) was analyzed exclusively using the 
N-terminally truncated enzyme variant zST8SiaII?N86. To exclude that the observed loss of 
activity in enzyme variants lacking this site is an artificial effect that results from depriving 
the transmembrane domain and parts of the stem region, the site-directed mutagenesis 
approach described in 1.3.3. was repeated using full length enzyme. N-terminally Flag-tagged 
N-glycosylation variants of full- length zST8SiaII were transiently expressed in CHO-2A10 
cells. These cells show no surface expression of polySia due to a defect in their intrinsic 
polysialyltransferase (Eckhardt et al., 1995). After 48 h, cells were fixed with 
paraformaldehyde and stained with polySia specific monoclonal antibody 735. Full- length 
zST8SiaII variants, lacking the third N-glycosylation site (?3), exhibited a dramatically 
reduced polySia surface staining compared to wild-type. Cells with weak polySia staining 
were only sporadically found for those variants and only seen when the exposure time was 
increased up to threefold (fig. 9 A). For all other variants no significant alterations were 
detectable (fig. 9 A). Comparable transfection efficiency and expression of all zST8SiaII 
variants was confirmed by additional immunofluorescence experiments using an antibody 
directed against the N-terminal Flag-tag (fig. 9 B). In summary this cellular assay proves the 
fundamental influence of N-glycosylation site N95 (#3) on zST8SiaII activity in the full-
length enzyme and verifies the results obtained using the truncated enzyme in vitro. 
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Figure 9: Polysialylation activity of N-glycosylation variants of full-length zebrafish ST8SiaII. 
N-terminally Flag-tagged wild-type and N-glycosylation variants of zST8SiaII were transiently 
expressed in polySia free CHO-2A10 cells. 48 h post transfection, cells were fixed with 
paraformaldehyde. A. PolySia surface staining using mAb 735 at 630-fold magnification. B. As 
expression control, cells were permeabilized and stained with an antibody directed against the N-
terminal Flag-tag at 630-fold magnification.  
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1.3.5. Baculoviral expression of secreted zST8SiaII 
 
Despite recent advances in the field of polysialyltransferases there is little known about the 
mechanism of polySia chain initiation, elongation and termination. To further investigate the 
catalytic mechanism, detailed biochemical studies using purified enzyme variants are 
indispensable. A complex expression system is required to obtain pure and active polySTs, 
due to the presence of essential disulfide bonds and N-glycosylation attachment sites. 
Although mammalian cell expression systems fulfill these requirements the yield of purified 
recombinant protein remains very low in comparison to the costs. To increase yields, a 
baculoviral based insect cell expression system (Invitrogen) was established and test-
expressions of truncated and minimally glycosylated zST8SiaII variants were performed. To 
facilitate detection and purification an N-terminal Histidine tag was added to all constructs 
and secretion to the culture medium was enforced by addition of the honey bee melittin 
secretion sequence. Supernatants of infected Sf9 cells were collected at different time points 
post infection and analyzed by SDS-PAGE - directly or after trichloric acetic acid 
precipitation - followed by western blot analysis using an anti-penta-His antibody. The 
resulting time response data of secreted zST8SiaII variants are shown in figure 10. 
zST8SiaII?N26, truncated only by the transmembrane domain, is secreted in high yield 
compared to zST8SiaII?N86, lacking also parts of the stem region. The minimally 
glycosylated construct zST8SiaII?N86D4D5 that maintains only N-glycosylation site N95 
was expressed and secreted in barely detectable amounts. 
 
 
Figure 10: Baculoviral expression 
of secreted zST8SiaII variants in 
Sf9 cells. Time response of 
baculoviral expression in Sf9 cells 
analyzing three N-terminally 
truncated forms of zST8SiaII (DN26, 
DN86, DN86D4D5) at which the last-
mentioned variant additionally lacks 
N-glycosylation sites 4 und 5. After 
24, 48, 72 and 96 h cell culture 
supernatants of infected Sf9-cells 
were analyzed by 10 % SDS-PAGE 
- directly (supernatant) and after 
trichloric acetic acid precipitation 
(1:20 concentrated)- followed by 
western blot analysis using an anti-
penta-His antibody. 
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Taken together the baculoviral expression study revealed that zST8SiaII can be produced in 
Sf9 insect cells in good quantities. However, parts of the stem region as well as the presence 
of N-glycosylation sites seem to have a major effect on protein yields. 
 
 
 
1.3.6. Purification of Histidine-tagged zST8SiaII from insect cells  
 
N-terminally His-tagged zST8SiaII?N26 and zST8SiaII?N86 constructs were expressed in 
Sf9 cells (fig. 11 A). 72 h post baculoviral infection, cell culture supernatants were 
concentrated to 80 ml and loaded on Ni2+-NTA-beads. zST8SiaII was subsequently eluted 
with 100 mM imidazole and the quaternary structure was determined using size-exclusion 
chromatography. Samples of all purification steps were analyzed by 10 % SDS-PAGE 
followed by silver staining and western blot analysis (fig. 11 B). Both enzyme variants could 
be significantly enriched by affinity chromatography with only one contaminant left as 
visualized by silver staining (Ni2+-NTA purified). Analysis of both enzymes after size-
exclusion chromatography revealed that zST8SiaII?N86 could be purified to homogeneity by 
this additional purification step, whereas the main part of zST8SiaII?N26 decomposed into 
several degradation products. Those additional bands occurring in the silver staining of 
zST8SiaII?N26 are not detectable in the western blot and are therefore most likely N-
terminal degradation products.  
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Figure 11: Purification of zST8SiaII?N26 and zST8SiaII?N86 from Sf9 cells. A. Schematic 
representation of the secreted N-terminally His-tagged zST8SiaII constructs, which were purified 
from insect cell culture supernatants. B. N-terminally His-tagged zST8SiaII variants were baculoviral 
expressed in Sf9 cells. 72 h post infection, secreted proteins were harvested by concentrating cell 
culture supernatant and incubated over night with Ni2+ -NTA-beads. Protein was eluted stepwise with 
imidazole and peak fractions were analyzed by 10 %SDS-PAGE followed by silver staining and 
western blot analysis using anti-penta-His antibody. 
 
Further analyses were carried out with the stable zST8SiaII?N86 enzyme variant. A final 
yield of up to 2 mg/L pure enzyme was obtained using the purification procedure described 
above.  
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 1.3.7. Sf9-cell expressed zST8SiaII?N86 is a monomeric protein displaying enzymatic 
activity 
 
To analyze the oligomerization state of zST8SiaII?N86 an analytical size-exclusion 
chromatography of Ni2+-NTA purified enzyme was performed using a Superdex 200 column 
that was calibrated with standard proteins. The elution profile is shown in figure 12 A. A 
single peak was obtained for zST8SiaII?N86 at a retention volume of 15.3 ml, which 
corresponds to a molecular mass of 37 kDa and is in perfect agreement with the calculated 
molecular mass of a monomer. All peak fractions were subsequently analyzed by SDS-PAGE 
followed by silver staining (upper panel) and western blot analysis using an anti-penta-His 
antibody (lower panel) to prove the presence of zST8SiaIIDN86 (fig. 12 B). Enzymatic 
activity of the pooled peak fractions were investigated in a radioactive incorporation assay in 
solution. Therefore zST8SiaII?N86 was incubated with 0.25 mM CMP-[14C]Neu5Ac in the 
presence of 1 µg NCAM, followed by SDS-PAGE and autoradiography (fig. 12 C). 
 
 
 
Figure 12: Size-exclusion chromatography of Histidine–tagged zST8SiaII?N86. The quaternary 
structure of Ni2+-NTA purified zST8SiaII?N86 was determined by size-exclusion chromatography 
using a Superdex 200 column. A. Elution profile of zST8SiaII?N86. Void volume (V0) and retention 
volumes of standard proteins are indicated. Peak fractions are shaded in grey. B. Peak fractions were 
analyzed by 10 % SDS-PAGE followed by silver staining (upper panel) or western blotting using an 
anti-penta-His antibody (lower panel). C. Enzymatic activity of pooled peak fractions was analyzed in 
a radioactive incorporation assay using 0.2 µg zST8SiaII?N86 in reaction buffer (10 mM sodium 
cacodylate buffer pH 6.7; 10 mM MnCl2) containing 0.25 mM CMP-[14C]-Neu5Ac, and 1 µg NCAM 
in a total volume of 20 µl. After 3 h incubation at 26°C samples were separated on 8 % SDS-PAGE 
before (-) and after (+) EndoneuraminidaseF (EndoNF) treatment and visualized by autoradiography.  
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Taken together, baculoviral expression of His-tagged zST8SiaIIDN86 in insect cells and 
subsequent affinity purification followed by size-exclusion chromatography, revealed an 
efficient possibility to obtain stable, pure, active and apparently monodisperse enzyme in 
high yields. This enabled us for the first time to start protein demanding biophysical studies 
on a eukaryotic polysialyltransferase.  
 
 
 
1.3.8. Adaptation of assay condition for NMR-spectroscopy studies 
 
To gain first insight into the reaction mechanism of eukaryotic polySTs, the purified 
zST8SiaIIDN86 described above was investigated by NMR spectroscopy. Binding properties 
of zST8SiaII?N86 towards different substrates were analyzed using Saturation-Transfer-
Difference-(STD)-NMR spectroscopy. In addition the minimal acceptor length for 
zST8SiaII?N86 activity was determined by 1H-NMR spectroscopy. Initially, the commonly 
used buffer system had to be adjusted to the requirements of NMR-spectroscopy to receive 
high resolution spectra. The Mn2+ cation, usually present in polyST activity assays had to be 
exchanged and a deuterated buffer system was needed. Therefore, polysialylation activity of 
zST8SiaIIDN86 was tested under various conditions in an ELISA based assay system. To 
substitute Mn2+, the influence of other divalent cations such as Mg2+ and Ca2+ was assayed. 
Furthermore, we analyzed whether the MES-buffer is exchangeable by the more convenient 
Tris-buffered system. The activity assays revealed that Mg2+ is most suitable to replace 
manganese cations as zST8SiaII?N86 maintained high levels of residual activity (fig. 13 A). 
Though using a Tris-buffered system affected enzyme activity, still sufficient residual activity 
was maintained. The Mg2+/Tris-system was further improved by optimizing Mg2+ 
concentrations (fig. 13 B). The best assay condition suitable for NMR-spectroscopy was 
found to be 1 mM Mg2+ in 10 mM Tris-buffer pH 6.8. In the following, all NMR-
spectroscopic analyses of zST8SiaII?N86 were carried out under these optimized conditions. 
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Figure 13: Adaption of assay conditions for NMR spectroscopy studies. For high resolution 
NMR-spectra, the standard assay conditions (2-(N-Morpholino) ethanesulphonic acid (MES)-buffer 
and Mn2+) were adjusted. 30 pg/well of ProtA-NCAM were adsorbed to a 96 well microtiter plate and 
incubated with 0.2 µg of zST8SiaII?N86 in reaction buffer containing 1 mM CMP-Neu5Ac for 4 h at 
27°C. A. Influence of buffer and divalent cation on zST8SiaII?N86 activity. B. Optimization of Mg2+ 
concentration at two different pH values.  
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1.3.9. Ligand binding analyses of zST8SiaII by STD-NMR spectroscopy  
 
This method is based on saturation transfer from the target protein to ligands mediated by 
spin-diffusion and allows the determination of the binding epitope of the ligand. Ligand 
protons, which are close to the protein surface, exhibit high STD-NMR signal intensities and 
are more likely to be involved in substrate binding (Mayer and Meyer, 2000).  
Binding properties of the substrate CMP-Neu5Ac towards zST8SiaIIDN86 were analyzed by 
STD-NMR spectroscopy using 100 µg purified enzyme in the presence of a 100fold molar 
excess of the activated sugar (fig. 14 a/b). Likewise, isolated nucleotide moiety CMP (c/d) 
and the sugar moiety Neu5Ac (e/f) were tested. In parallel, 1H-NMR-spectra were acquired 
for each ligand to allow assignment of all ligand specific peaks in the respective STD-NMR 
spectra. Comparison of the STD-NMR (upper panel) with the corresponding 1H-NMR 
spectrum (lower panel) revealed that all protons of CMP-Neu5Ac were detectable in both 
experiments (fig. 14 a/b). Therefore, all protons of CMP-Neu5Ac are assumed to be in close 
contact to zST8SiaII?N86. The same observation was made for the nucleotide moiety CMP 
(fig. 14 c/d). Interestingly, no saturation transfer from zST8SiaII?N86 to protons of the sugar 
moiety Neu5Ac was detectable. Peaks that are visible in the STD-NMR spectrum of 
zST8SiaII?N86 in the presence of Neu5Ac are not in phase (fig. 14 e/f).  
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Figure 14: Binding properties of the activated sugar CMP-Neu5Ac. Spectra are shown for 
Neu5Ac (a/b), CMP (c/d) and CMP-Neu5Ac (e/f). 100 µg of purified zST8SiaII?N86 were incubated 
in deuterated reaction buffer (10 mM Trisd5/DCl, 1 mM MgCl2, pH 6.8) containing a 100fold molar 
excess of the substrate at 10°C. To assign STD signals, corresponding 1H-NMR spectra are depicted 
below the respective STD spectra.  
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Taken together, STD-NMR experiments of zST8SiaII?N86 suggest that the complete CMP-
Neu5Ac molecule is bound to the enzyme, whereby the nucleotide moiety appears to be 
crucially involved in substrate binding.  
 
 
Next, we were interested to study the binding properties of the acceptor substrates. Therefore, 
100 µg ST8SiaII?N86 were incubated with a 100fold molar excess of a2,3-sialyllactose 
which mimics the natural Neu5Aca2à3Galß1àR acceptor site used by ST8SiaII in vivo and 
sialic acid oligomers (degree of polymerization (Dp) Dp2-Dp6).  
In this STD-NMR-study saturation transfer was observed for a2,3-sialyllactose 
predominantly found for H 3eq (2,3 ppm) and NHAc (1,75 ppm) of the Neu5Ac moiety, 
indicating that the recognition site of this acceptor seems to be the Neu5Ac moiety 
(fig. 15 a/b).  
Saturation transfer was found for all sugar moieties of the artificial acceptors Dp2 
(fig. 15 c/d), Dp3 (e/f) and Dp6 (g/h). This is demonstrated by the respective signals obtained 
for the H 3eq proton of Neu5Ac, which allows to discriminate external sugar moieties in a-
configuration (aex), from internal residues in a-configuration (ain) and external residues in b-
configuration (ßex). The ratio of these peak areas demonstrates that zST8SiaIIDN86 binds 
oligosialic acids from dimer to hexamer. This suggests that parts of the growing polyS ia 
chain stay in close contact to the enzyme. 
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Figure 15: Binding properties of artificial acceptors analyzed by STD-NMR. Spectra are shown 
for a2,3-sialyllactose (a/b), Dp2 (c/d), Dp3 (e/f), and Dp6 (g/h). 100 µg of purified zST8SiaII?N86 
were incubated in deuterated reaction buffer (10 mM Trisd5/DCl, 1 mM MgCl2 , pH 6.8) containing a 
100fold molar excess of the substrate at 10°C. To assign STD signals, the corresponding 1H-NMR 
spectrum of the respective ligand is depicted below each STD-NMR spectrum.  
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Binding properties of the artificial acceptors (2,3-sialyllactose, Dp2, Dp3, Dp6) towards 
zST8SiaII?N86 did not alter in the presence of CMP-Neu5Ac (data not shown). 
Consequently, we assume that artificial acceptors and the donor substrate CMP-Neu5Ac bind 
independently to zST8SiaII?N86.  
 
 
 
1.3.10. Activity studies for zST8SiaII?N86 by 1H-NMR spectroscopy  
 
Until now, only little is known about the minimal sugar-acceptor structure for polySTs. 
Accordingly, low levels of enzymatic activity were observed for oligosaccharides alone 
(Angata et al., 2000; Angata, Suzuki, and Fukuda, 2002). Using STD-NMR spectroscopy, we 
could already demonstrate ligand binding of short oligosaccharides to zST8SiaII?N86 
(1.3.9). Next, we established an NMR-based assay to determine the minimal acceptor 
structure for polyST activity. Therefore, 100 µg ST8SiaII?N86 were incubated with a 
100fold molar excess of CMP-Neu5Ac and sialic acid oligomers. For this approach we used 
1H-NMR spectroscopy to monitor zST8SiaII?N86 activity towards different mono- and 
oligosaccharide acceptors continuously. The relative integrals for the enzymatic reaction of 
zST8SiaII?N86 with CMP-Neu5Ac and the artificial acceptor Dp6 are depicted in 
figure 16 A. The reduction of the H 3eq CMP-Neu5Ac signal (0.426) corresponds directly 
with an increase of the ain H 3eq oligoSia signal (0.520), whereas the aex and ßex H 3eq 
signals of oligoSia remain constant. The broadening of a in H 3eq signals at 2.45 ppm strongly 
suggested the synthesis of a sialic acid polymer (>Dp6). The same results were obtained with 
the acceptor Dp3. The reduction of the H 3eq CMP-Neu5Ac signal (0.499) corresponds 
directly with an increase of the ain H 3eq of polySia signal (0.312), whereas the aex and ßex 
H 3eq signals of polySia remained constant (fig. 16 B). In the case of the acceptor a2,3-
sialyllactose, product formation of Neu5Aca(2,8)-Neu5Aca(2,3)-Galactoseß(1,4)-Glucose, 
was monitored by the developing H 3eq signal of the internal aNeu5Ac (Neu5Ac a in) at 
2.45 ppm (fig. 16 C).  
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Figure 16: Acceptor studies for zST8SiaII?N86 by 1H-NMR spectroscopy. 1H-NMR-spectra are 
shown for zST8SiaII?N86 activity with oligoSia hexamer (A), trimer (B) and a2,3-sialyllactose (C). 
100 µg of purified zST8SiaII?N86 were incubated in deuterated reaction buffer (10 mM Trisd5/DCl, 
1 mM MgCl2 , pH 6.8) containing a 100fold molar excess of CMP-Neu5Ac and acceptor.  
In A. the relative integrals for CMP-Neu5Ac and DP6 before (grey) and after (black) incubation with 
zST8SiaII?N86 are depicted. The reduction of the H3eq CMP-Neu5Ac signal (0.426) corresponds 
directly with an increase of the ain H 3eq of polySia signals (0.520). Broadening of ain H 3eq signals 
at 2.45 ppm strongly suggests the synthesis of a sialic acid polymer. In B. the reduction of the H 3eq 
CMP-Neu5Ac signal (0.499) corresponds directly with an increase of the a in H 3eq of polySia signal 
(0.312), whereas the aex and ßex H 3eq signals of polySia remained constant. In C. the spectra reveal 
the formation of Neu5Aca(2,8)-Neu5Aca(2,3)-Galactoseß(1,4)-Glucose from a2,3-sialyllactose and 
CMP-Neu5Ac by zST8SiaII?N86. The H 3eq signal of the rising internal aNeu5Ac (Neu5Ac a in) is 
visible at 2.45 ppm. NMR integration error: ±10-15 %. 
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All artificial acceptors tested by STD-NMR and 1H-NMR spectroscopy were found to bind to 
zST8SiaII?N86 and shown to serve as acceptor substrates for chain elongation. The only 
exception was monomeric Neu5Ac.  
The Sia monomer is mainly present in b-configuration (95%), whereas the oligomeric 
acceptors are in a-configuration at the non-reducing end. To analyze if a-configuration is 
essential for recognition by the enzyme, we tested a monomer with a fixed a-configuration 
(Neu5Aca2Me) as a putative acceptor for zST8SiaII?N86. 
Interestingly, zST8SiaII?N86 was indeed capable to transfer sialic acid from the activated 
sugar CMP-Neu5Ac to the a-anomer of Neu5Aca2Me (fig. 17 A). Under the applied 
conditions, no polymer but exclusively the Neu5Aca(2,8)-Neu5Aca2Me dimer was formed 
due to the high molar excess of the a-anomer. As expected, incubation of zST8SiaII?N86 
with the corresponding ß-anomer Neu5Acß2Me or free Neu5Ac (a : ß; 5 %:95 %) did not 
result in the formation of detectable amounts of dimer (fig. 17 B). Due to hydrolysis of 
unstable CMP-Neu5Ac (2.3 ppm) the formation of an addit ional peak for free Neu5Ac (free 
NHAc (1.83 ppm)) occurs over time (fig. 17 B).  
 
 
For the first time we succeeded in demonstrating that a-configuration at the non-reducing end 
of the acceptor substrate is crucial for polyST activity. In addition, these findings indicate that 
the minimal acceptor length required for zST8SiaII?N86 activity is a monomer. 
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Figure 17: Minimal acceptor length required for zST8SiaII?N86 activity. 1H-NMR-spectra of 
zST8SiaII reactions using an a- or ß- Sia anomer (Neu5Ac(a or ß)2Me) were acquired to define the 
minimal acceptor for zST8SiaII?N86 activity. 100 µg of purified zST8SiaII?N86 were incubated in 
deuterated reaction buffer (10 mM Trisd5/DCl, 1 mM MgCl2, pH 6.8) containing a 100fold molar 
excess of CMP-Neu5Ac and a- or ß- Sia anomer for 15 h at 20°C. 
In A. the zST8SiaII?N86 activity on Neu5Aca2Me is depicted. The signals at 2.38 ppm and 2.55 ppm 
suggest the synthesis of a Neu5Aca(2,8)-Neu5Aca2Me dimer. For the corresponding Neu5Acß2Me 
no product peak was observed. Non-enzymatic hydrolyses of unstable  CMP-Neu5Ac is indicated by 
the appearance of a peak at 1.83 ppm for the NHAc of free Neu5Ac. 
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1.3.11. Crystallization attempts of zST8SiaII?N86 
 
Currently, no information is available on the 3D-structure of polysialyltrans ferases. None of 
the prokaryotic or eukaryotic polySTs have been crystallized so far. Also, structure prediction 
software did not allow similarity building of any 3D-model for members of the a2,8-
sialyltransferase family. For the first time we succeeded in purifying a eukaryotic polyST to 
homogeneity in high yields, enabling us to start a comprehensive crystallization approach. 
Therefore the pure His-tagged zST8SiaII?N86 variant was used for crystal screening in the 
presence or absence of the donor analogue CMP-Neu5Ac3F (Mueller-Dieckmann, 2006). As 
a first result, we obtained two initial conditions containing precrystals as depicted in 
figure 18. An extensive approach is required to optimize crystallization conditions and to 
solve the 3D-structure, which is far beyond the scope of the present study.  
 
 
 
Figure 18: Crystallization experiments for zST8SiaII?N86. Pictures of precrystals at different 
timepoints (left panel) and the corresponding crystallization conditions (right panel) are depicted.  
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1.4. Discussion 
 
Poly-a2,8-sialic acid (polySia) is a posttranslational modification of the neural cell adhesion 
molecule (NCAM) and an important regulator of NCAM-mediated cellular plasticity. The 
two enzymes involved in polySia biosynthesis in vertebrates are the polysialyltransferases 
(polyST), ST8SiaII and ST8SiaIV (Eckhardt et al., 1995; Nakayama et al., 1995; 
Scheidegger et al., 1995; Kojima et al., 1995). During development, polySia biosynthesis is 
mainly mediated by ST8SiaII whereas ST8SiaIV is the predominant enzyme in adults 
(Oltmann-Norden et al., 2008). In addition to its essential role in neural development, polySia 
represents an oncodevelopmental antigen that is re-expressed on several malignant tumors. 
Expression of polySia in the tumors facilitates detachment of cells from the primary tumor 
and thus promotes the first step in metastasis (Roth et al., 1988; Fukuda, 1996; Zuber et al., 
2005; Scheidegger et al., 1994; Tanaka et al., 2001; Glüer et al., 1998b; Glüer et al., 1998a; 
Hildebrandt et al., 1998; Seidenfaden et al., 2003). Enzymes involved in polySia 
biosynthesis, therefore, represent attractive targets for anti-cancer therapy. Although the 
mammalian polySTs have been cloned back in 1995 (Eckhardt et al., 1995; Nakayama et al., 
1995; Scheidegger et al., 1995; Kojima et al., 1995) there is still little known about the 
catalytic mechanism and structural features of these important enzymes.  
Detailed analyses of structure-function relationships in polySTs are mainly hampered by the 
lack of expression systems capable to supply sufficient amounts of active enzymes. The 
tertiary organization of these type-II-transmembrane glycoproteins that involve two essential 
disulfide bonds and up to six partly polysialylated N-glycans impedes the development of 
straight forward approaches for the purification of polyST. The integrity of the N-glycan 
attachment sites N89 (3) and N219 (5) of the mammalian enzymes is crucial for ST8SiaII 
activity (Mühlenhoff et al., 2001; Close et al., 2001). Interestingly, however, the homologous 
enzyme from the lower vertebrate zebrafish (zST8SiaII) lacks one out of these two crucial N-
glycosylation sites whereupon a functional enzyme is maintained (Marx et al., 2007). 
Therefore, we speculated that a single N-glycan in zST8SiaII might be sufficient to obtain a 
stable and active enzyme variant. Based on this assumption zST8SiaII was selected as a 
suitable candidate for an extensive protein engineering and purification approach.  
To determine the minimal active enzyme variant of zST8SiaII we analyzed a set of N-
terminally truncated variants with regard to activity and expression levels. As shown in 
figure 7, zST8SiaII could be truncated by up to 86 amino acids without significant loss of 
enzymatic activity. This experiment shows that the first two N-glycosylation attachment sites 
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(N51 and N86) are of minor importance as the truncated, but fully active enzyme, 
zST8SiaIIDN86 lacks both sites.  
To investigate the impact of the remaining three N-glycosylation sites of zST8SiaII, a 
comprehensive site-directed mutagenesis approach was performed based on the construct 
zST8SiaII?N86. Only N-glycosylation site N95 (#3) was found crucial for enzymatic activity 
(fig. 8) consistent with the data published for the corresponding N-glycan attachment site of 
the mouse homologue (Mühlenhoff et al., 2001), emphasizing the importance of this highly 
conserved site in vertebrate ST8SiaIIs. In addition, N-glycosylation site N140 (#4) is highly 
conserved in vertebrates although no significant effect on polyST activity is known so far 
(Mühlenhoff et al., 2001; Close et al., 2001). 
A unique feature of zST8SiaII among the eukaryotic polySTs is the positioning of N-
glycosylation attachment site N174 (#5) which is surprisingly located in the conserved L-
motif. Single amino acid substitution zST8SiaIIDN86-N174Q lacking this N-glycosylation 
site, revealed a shift in molecular mass compared to the corresponding enzyme variant 
harboring the site, when analyzed by SDS-PAGE (fig. 8). This finding highlights the 
accessibility of N-glycosylation site N174 located within the L-motif, supporting the 
assumption that the L-motif is part of the outer surface as described previously (Angata et al., 
2001). Interestingly, no effect on neither enzymatic activity nor expression efficiency was 
detectable in the zST8SiaII variant lacking N-glycosylation site N174 (#5) (fig. 8).  
The relevance of N-glycosylation sites #3, #4 and #5 of zST8SiaII was investigated based on 
the truncated enzyme variant that lacks the first 86 amino acids. To exclude artificial effects 
resulting from the loss of the transmembrane domain and parts of the stem region, the study 
was repeated by expressing full- length enzymes in polySia-free CHO cells. Using this 
additional assay system we could unequivocally confirm that zST8SiaII activity crucially 
depends on the presence of N-glycan N95 (#3), whereas the mammalian homologues require 
at least a second N-glycan (Mühlenhoff et al., 2001). Consequently we assumed zST8SiaII to 
be a suitable candidate for successful high yield purification.  
Subsequently, we were interested to determine the system suitable for high- level expression 
of active zST8SiaII. Because folding of polyST depends on two disulfide bonds and the 
presence of an N-glycan, the bacterial expression systems were mostly inapplicable. Hitherto, 
mammalian expression systems allowed only low-level expression of functional polySTs that 
are not sufficient for a detailed biochemical characterization. 
We chose insect cell expression, which is well established for high yield expression of 
recombinant proteins and that guarantees basic glycosylation structures and correct formation 
   Chapter 1 - Discussion 
 
 53 
of disulfide bonds. As shown in figure 10 the baculovirus system generated high amounts of 
recombinant N-terminally truncated zST8SiaII variants. Best expression efficiency was 
observed for N-terminally truncated zST8SiaII variants lacking 26 and 86 amino acids, 
respectively. Unfortunately, drastically reduced expression was detected with the enzyme 
variant harboring only one N-glycosylation site (fig. 10). This effect is consistent with our 
observations in the mammalian system. Using an ELISA to estimated protein concentration 
of N-glycosylation depletion variants of ProtA-ST8SiaII?86 we could demonstrate an up to 
fourfold decrease in expression levels for the ProtA-ST8SiaII?86?3?4?5 variant (data not 
shown). Based on these results the variants zST8SiaIIDN26 and zST8SiaIIDN86 were chosen 
for purification of the secreted His-tagged enzymes from Sf9 cells (fig. 11). To our surprise 
we found that zST8SiaII?N26 was N-terminally degraded while zST8SiaII?N86 remained 
stable after purification. Therefore, we used zST8SiaII?N86 for large-scale production of 
recombinant enzyme from insect cell supernatants, resulting in a final yield of up to 2 mg/L.  
 
The quaternary state of zST8SiaII?N86 was determined by size-exclusion chromatography, 
indicating the monomer as the functional active unit (fig. 12). This result is consistent with 
the data published on human ST8SiaIV. In the presence or absence of reducing agents, this 
polyST was found as a monomer when analyzed by SDS-PAGE (Angata et al., 2001). 
Purification of functional zST8SiaII?N86 in high yield enabled us to start new approaches to 
analyze the biochemical properties of polySTs. Binding properties of substrates towards 
zST8SiaIIDN86 were investigated by Saturation-Transfer-Difference (STD)-NMR 
spectroscopy. Interaction of the donor substrate CMP-Neu5Ac with zST8SiaII?N86 is 
predominantly mediated by the nucleotide moiety, as highest saturation transfer was observed 
for this part of the molecule. Similar observations were recently described for ß-galactoside 
a2,6-sialyltransferase (ST6GalI), another member of the a2,8-sialyltransferase family (Liu, 
and Prestegard, 2007). In addition no binding of Neu5Ac alone was detectable (fig. 14), 
arguing for that the nucleotide moiety of CMP-Neu5Ac has a major impact on first binding 
contacts and guidance of the substrate to the active site. Binding studies of the acceptor 
substrate polySia towards zST8SiaII?N86 were carried out using defined sialic acid 
oligomers such as dimers, trimers and hexamers. Interestingly, the dimer received decreased 
amounts of saturation transfer compared to the longer chain oligomers, indicating that more 
than two Sia residues might be in close contact to the active site.  
Furthermore, enzymes acting on polymeric substrates can possess additional (secondary) 
substrate binding sites that are not necessarily located in close proximity to the active site as 
   Chapter 1 - Discussion 
 
 54 
recently shown for the polySia degrading enzyme endoneuraminidase F (Stummeyer et al., 
2005). The highly conserved PSTD motif restricted to polysialyltransferases of the a2,8-
sialyltransferase protein family, might constitute an additional polySia binding site. The 
PSTD is a structurally unique polybasic motif (pI~12) and was postulated previously to tether 
nascent polySia chains, facilitating the processive addition of new Neu5Ac residues to the 
non-reducing end of the growing chain (Nakata, Zhang, and Troy, 2006). 
For a2,3-sialyllactose which mimics an acceptor site used by ST8SiaII in vivo, saturation 
transfer was predominantly found for the Neu5Ac moiety, suggesting that ST8SiaII interacts 
rather with sialic acid residues than with the entire N-glycan structure. Although it has to be 
taken into account that these results were obtained for artificial, protein-free acceptor 
substrates, using a soluble truncated polyST in vitro. Using STD-NMR spectroscopy, we 
succeeded for the first time in demonstrating interaction of zST8SiaII?N86 with defined 
short-chain oligoSia in vitro, although enzymatic activity of polyST towards a mixture of 
oligoSia and monosialyl-oligosaccharids was reported previously (Angata et al., 2000). Using 
1H-NMR-spectroscopy to observe zST8SiaII?N86 reaction on sialic acid hexamers, trimers, 
and 2,3-monosialyl trisaccharids, we could confirm enzymatic activity for zST8SiaII?N86. 
 
Moreover, STD-NMR studies revealed that a sialic acid dimer is bound to zST8SiaII?N86 
whereas Neu5Ac alone showed no significant interaction. Comparison of these two 
molecules displays that nearly 95 % of Neu5Ac are present in the ß-configuration, whereas 
the non-reducing end of a dimer is fixed in a-configuration. As chain elongation of polySia 
mediated by polySTs takes place at the non-reducing end, the configuration of this sialic acid 
residue might be significant for binding and zST8SiaII?N86 activity. To verify the 
hypothesis that an a-configuration of Neu5Ac at the non-reducing end is required for chain 
initiation and elongation we analyzed sialic acid derivatives fixed in the a- or b- 
configuration (Neu5Aca2ME and Neu5Acb2ME) as well as free Neu5Ac by 1H-NMR 
spectroscopy. As expected, only Neu5Ac in a-configuration could initiate chain elongation 
demonstrating that an a-configuration at the non-reducing end is a prerequisite for 
zST8SiaII?N86 activity. These results indicate that even a monomer might be sufficient to 
prime polyST mediated chain elongation.  
To gain further insight into the catalytic mechanism of polySTs with regard to chain 
initiation, elongation and termination, the accessibility to structural data would be a valuable 
source. But so far, no 3D structural data for polySTs are available and prediction software 
does not allow similarity building of 3D models for any of the members of the a2,8-
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sialyltransferase family. For the first time we succeeded in purifying a eukaryotic polyST to 
homogeneity and generated high yields which enabled us to start crystallization trials. Initial 
promising precrystals (fig. 18) were obtained for zST8SiaII?N86 that have to be optimized in 
further studies.  
In conclusion, we succeeded to purify zST8SiaIIDN86 to homogeneity in high yield that 
enabled us to start a comprehensive biochemical characterization of the eukaryotic enzyme. 
STD-NMR spectroscopy studies of zST8SiaII?N86 allowed a first insight into substrate 
binding properties and provide a basis for further studies aiming at understanding the 
catalytic mechanism of eukaryotic polySTs.  
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Chapter 2:  
Engineering of murine ST8SiaII to a non N-glycosylated 
polysialyltransferase 
 
2.1. Introduction  
 
Polysialic acid (polySia) is a linear homopolymer comprised of up to 90 N-acetylneuraminic 
acid residues in an a2,8- linkage (Brisson et al., 1992; Galuska et al., 2008). In vertebrates, 
polySia is predominantly found as posttranslational modification of the neural cell adhesion 
molecule (NCAM) (Rothbard et al., 1982; Hildebrandt, Mühlenhoff, and Gerardy-Schahn, 
2008), although three other polySia carriers have been identified, the a subunit of the voltage 
dependent sodium channel (Zuber et al., 1992), the scavenger receptor CD36, identified as 
soluble protein in human breast milk (Yabe et al., 2003) and, as shown in a most recent 
study, neuropilin-2 expressed on matured dendritic cells (Curreli et al., 2007). PolySia can be 
added to N-glycans and O-glycans of the respective acceptor structures. Concerning NCAM, 
only N-glycans have been reported to be polysialylated in vivo whereas recent cell-culture 
experiments using the full- length enzyme as well as several domain deletion variants of 
NCAM pointed out that O-glycans can be used as alternative acceptor sites (Close et al., 
2003; Colley, 2008). For CD36 and neuropilin-2, polySia is reported on O-glycans, 
exclusively (Yabe et al., 2003; Curreli et al., 2007). PolySia transferred onto the synthesizing 
enzymes, the polySTs, by contrast, is N-glycosidically linked (Mühlenhoff et al., 2001).  
The biosynthesis of polySia in vertebrates is mediated by two polySTs, ST8SiaII and 
ST8SiaIV and both enzymes have been cloned and characterized from mammals (Eckhardt et 
al., 1995; Nakayama et al., 1995; Scheidegger et al., 1995; Kojima et al., 1995). 
Simultaneous depletion of these genes generated a polySia-negative phenotype and thus 
proved that no other polyST exists in the mammalian system (Weinhold et al., 2005).  
Eukaryotic polySTs share four highly conserved motifs and two disulfide bonds that are 
essential for enzymatic activity (Datta and Paulson, 1995; Datta, Sinha, and Paulson, 1998; 
Kitazume-Kawaguchi, Kabata, and Arita, 2001; Nakata, Zhang, and Troy, 2006; Angata et 
al., 2001). Furthermore, six and five N-glycan attachment sites have been identified in 
mammalian ST8SiaII and ST8SiaIV, respectively. For the murine ST8SiaII (mST8SiaII) N-
glycans in positions N89 and N219 are critical for enzymatic activity whereas mST8SiaIV 
crucially depends on the presence of N-glycosylation site N74 (Mühlenhoff et al., 2001; 
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Close et al., 2001). Interestingly, specific N-glycosylation sites in polySTs are polys ialylated 
in a self-modification reaction called autopolysialylation (Mühlenhoff et al., 2001).  
To gain further insight into the catalytic mechanism of polyST mediated polySia assembly, 
detailed in vitro studies are necessary that require large quantities of recombinant polyST.  
However, the production of functional recombinant enzymes requires N-glycosylation 
competent expression systems that also support the formation of disulfide bonds (Mühlenhoff 
et al., 2001; Angata et al., 2001). Therefore, bacterial expression systems that allow low-cost 
and time-saving large-scale production of recombinant enzymes have, with a single 
exception, so far failed to generate the functionally active enzymes. The exception is the 
monosialyltransferase ST3Gal-V, which has been obtained as functional recombinant enzyme 
after bacterial expression, even though the enzyme was previously demonstrated to depend 
on the presence of three N-glycans (Uemura et al., 2006).  
A surprising observation was that N-glycosylation sites even though defined as functionally 
important, are not necessarily conserved in homologous enzymes among species. A recent 
publication demonstrated that N-glycan functions can be replaced by a specific stretch of 
amino acids present at the equivalent position in homologous enzymes resulting in a non-
glycosylated but functional interspecies variant (Uemura et al., 2006). Uemura and coworkers 
who identified this phenomenon recently, made use of it to generate an N-glycan free form of 
the a2,3-sialyltransferase ST3Gal-V. In their study, the authors replaced the non-conserved 
N-glycan by the identified SUNGA (for substitution of N-glycan functions in 
glycosyltransferases by specific amino acids) sequence and generated a non-glycosylated but 
functional enzyme that could be expressed in bacteria (Uemura et al., 2006). Beside the 
applicability of cost-effective, large-scale production of recombinant enzymes in bacteria, 
engineered non-glycosylated enzyme variants would provide further advantages. For instance 
increased protein homogeneity should improve the suitability of the enzyme fraction for 
protein crystallization.  
Therefore, the second goal of my PhD study was to generate a polyST variant with no- or a 
minimal number of N-glycans by use of the SUNGA technique. As shown in this part, I 
succeeded in generating N-glycan free mST8SiaII variants that maintained enzymatic activity 
and allowed soluble expression using a bacterial system. 
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2.2. Experimental Procedures 
 
2.2.1. Materials 
Endoneuraminidase NF (endoNF) was purified from Escherichia coli K1 bacteriophage as 
described previously (Gerardy-Schahn et al., 1995). Recombinant soluble proteinA NCAM 
was expressed in CHO 2A10 cells and purified as described in Mühlenhoff et al. (1996).  
The plasmids pFlagST8SiaII, pFlagST8SiaII Q3N5, pFlagST8SiaII Q3Q5, pProtA-ST8SiaII, 
pProtA-ST8SiaII Q3N5, and pProtA-ST8SiaII Q3Q5 were kindly provided from Dr. 
Mühlenhoff from our laboratory (Mühlenhoff et al., 2001). The plasmid 
pSecTagST8SiaII?N31 was kindly provided by Dr. Stummeyer from our laboratory. 
2.2.2. Sequence analyses of polySTs 
Multiple sequence alignment was generated with MultAlin (Corpet, 1988) using the following 
accession numbers: 
mouse: NP_033207 
chicken: NP_001001604 XP_413877 
african clawed frog: AB007468.1 
zebrafish: NP_705948 
pufferfish: CAG29377 
2.2.3. Site-directed mutagenesis of mST8SiaII 
N-glycosylation site deficient mST8SiaII variants were generated by PCR using the 
QuikChange site-directed mutagenesis kit (Stratagene) following the manufactures 
guidelines. N-glycosylation sites were disrupted by substituting the asparagine (N) in the N-
X-S/T motifs by serine (S) or methionine (M). For site directed mutagenesis the plasmids 
pFlagST8SiaII Q3Q5 or pFlagST8SiaII Q3N5 were used as template. The primer pairs used are 
listed below (point mutations are in bold): 
N89Ss:CATCCAAATGGAGACACTCACAGA CGCTCTCTCTGAG 
N89Sas:CTCAGAGAGAGCGTCTGTGAGTGTCTCCATTTGGATG 
N219Ss:GAGGACCTTGTGTCGGCCACGTGGCGGG 
N219Sas:CCCGCCACGTGGCCGACACAAGGTCCTC 
VNAT(218-221)ASEEs:GGCCTTTGAGGACCTTGCGAGCGAGGAGTGGCGGGAGAA 
GCTGCTG 
VNAT(218-221)ASEEas:CAGCAGCTTCTCCCGCCACTCCTCGCTCGCAAGGTCCTC 
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AAAGGCC 
VNAT(218-221)AMEEs:GGCCTTTGAGGACCTTGCGATGGAGGAGTGGCGGGAGA 
AGCTGCTG 
VNAT(218-221)AMEEas:CAGCAGCTTCTCCCGCCACTCCTCTATCGCAAGGTCCTC 
AAAGGCC 
PCR products were subcloned into EcoRI sites of pFlagST8SiaII Q3Q5 or 
pFlagST8SiaII Q3N5 and the identity of all constructs was confirmed by sequencing. To 
obtain the corresponding ProtA-fusion proteins, the EcoRI digested PCR product was 
subcloned into EcoRI sites of pProtAST8SiaII Q3Q5 or pProtAST8SiaII Q3N5. For 
immunofluorescence staining soluble expressed ST8SiaII S3AS5EE variant was generated by 
subcloning of the EcoRI digested PCR product into EcoRI sites of pSecTag-ST8SiaII?N31. 
The vector pSecTag (Invitrogen) encodes the sequence of Ig? -chain leader and a C-terminal 
myc epitope followed by a hexa histidine tag (His). The plasmid pSecTag-ST8SiaII?N31 
drives the expression of secreted C-terminal Myc-His-tagged ST8SiaII?N31. 
2.2.4. Expression plasmids  
To construct N-terminally truncated and tagged mST8SiaII Q3AS5EE variants for expression 
in bacteria, mST8SiaII Q3AS5EE was amplified from the plasmid pFlagST8SiaII Q3AS5EE 
using the following primer pair (restriction sites are in bold): 
AG47s: GCGAAGCTTTGATCGGGAATTCTGGAGGC 
AG48as: GCCTCGAGTTACGTAGCCCCATCACAC 
PCR products were digested with HindIII and XhoI, gel purified (Qiagen) and ligated into the 
corresponding restriction sites of pET43-Strep, a modified pET43 vector (Novagen) 
containing the sequence encoding an N-terminal NusA fusion protein and Strep-tag II 
followed by a thrombin cleavage site. The resulting plasmid pET43-Strep-ST8SiaII Q3AS5EE 
drives the expression of N-terminally NusA-StrepII- fusion proteins. The insert was further 
subcloned into HindIII and XhoI sites of a modified pET43 expression vector containing the 
sequences encoding a N-terminal MBP fusion protein, FactorXa cleavage site, Strep-tagII 
and a thrombin cleavage site. The resulting plasmid pET43-MBP-ST8SiaII Q3AS5EE drives 
the expression of N-terminally MBP-StrepII- fusion protein. As described above the plasmid 
encoding N-terminal Strep-II tagged mST8SiaII Q3AS5EE was generated using a modified 
vector pET22 (Novagen). 
To construct N-terminally truncated mST8SiaII Q3AS5EE variant containing a C-terminal tag 
for expression in bacteria, mST8SiaII Q3AS5EE was amplified from the plasmid 
pFlagST8SiaII Q3AS5EE using the following primer pair (restriction sites are in bold) : 
   Chapter 2 - Experimental Procedures 
 
 60 
MM39s: CATGCCATGGAAATCGGGAATTCTGGA 
AG50as: CGCTCGAGCGTAGCCCCATCACACTG 
The resulting PCR product was digested with NcoI and XhoI and after gel purification 
(Qiagen) ligated into the corresponding restriction sites of pET23 (Novagen). The resulting 
plasmid pET23-ST8SiaII Q3AS5EE-His drives the expression of C-terminally His-tagged 
protein. 
To construct N-terminally truncated mST8SiaII S3AS5EE for expression in insect cells, the 
plasmid pFlag-ST8SiaII S3AS5EE was digested with EcoRI. After gel purification (Qiagen) 
the obtained DNA-fragment was subcloned into EcoRI sites of pFastBac-HBM-
mST8SiaII?31, a modified pFastbac1 vector (Invitrogen) containing a honeybee melitin 
(HBM) secretion signal and a N-terminal His-tag. The plasmid mST8SiaII?31 was kindly 
provided by Dr. Stummeyer from our laboratory. The identity of all constructs was confirmed 
by sequencing. 
2.2.5. Cultivation of LMTK- and CHO cells 
Mouse fibroblast cells (LMTK-) and Chinese hamster ovary (CHO)-2A10 cells were kept in a 
humidified incubator at 37°C and 5 % CO2. Cells were cultured in DMEM/HAM’s F12 
medium (Biochrom) supplemented with 5 % fetal calf serum (biochrom) and 1 mM sodium 
pyruvate (Gibco BRL). Confluent cell layers were treated with PBS/EDTA to detach the cells 
from culture vessels and diluted 1:20 in fresh medium. 
For long term storage in liquid nitrogen, cells were pelleted by centrifugation (5 min, 200xg, 
RT) and resuspended in culture medium containing 20 % fetal calf serum and 10 % DMSO at 
a concentration of 1x107 cells/ml. Aliquots of 1 ml were filled in cryo vials, stored overnight 
at -80°C and then transferred to liquid nitrogen. 
To recover frozen cell pellets, they were kept on dry ice for 5 min, thawed in a water bath at 
37°C and diluted by drop wise addition of culture medium containing 10 % fetal calf serum. 
After centrifugation (5 min, 200xg, RT) the cell pellet was resuspended in culture medium 
containing 10 % fetal calf serum and transferred to culture vessels. 
2.2.6. Cultivation of Sf9 cells 
Suspension cultures of Spodoptera frugiperda (SF9) cells were cultivated at 27°C and 90 rpm 
in protein free Insect XPress-medium (BioWhittaker). Cell density was maintained between 
0.5x106 and 5x106 cells per millilitre by diluting dense cultures in fresh medium. 
For long term storage in liquid nitrogen, cells were pelleted by centrifugation (5 min, 200xg, 
RT) and resuspended in the conditioned culture medium containing 10 % DMSO at a 
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concentration of 2x107 cells/ml. Aliquots of 1 ml were filled in cyro vials and cooled down 
by subsequent incubations at 4°C and -20°C for 1 h each. Cells were stored overnight at  
-80°C and then transferred to liquid nitrogen. 
To recover frozen cell pellets, they were kept on dry ice for 5 min, thawed in a water bath at 
37°C and directly added to 30 ml culture medium in a culture vessel. 
2.2.7. Transfection of LMTK- and CHO cells 
For immunofluorescence staining 0.9x105 cells were seeded per well of a six well tissue 
culture plate, containing coverslips. Cells were cultivated overnight as described in 2.2.5. For 
transient transfection a transfection mix was prepared by diluting 1 µg DNA and 6 µl 
Lipofectamin in 100 µl OptiMEM each. Both dilutions were combined and incubated for 
30 min at RT. The LMTK- cell layer (70-80 % confluent) was washed two times in PBS and 
incubated with freshly prepared transfection mix diluted in 1 ml OptiMEM for 5 h. The 
transfection was stopped by replacement of the transfection mix with 2 ml culture medium. 
Cells were cultivated for an additional 48 h. 
For the in vitro assay (2.2.15) 1.9x106 CHO-2A10 cells were seeded per 100 mm culture 
vessels and cultivated in a humidified incubator at 37°C and 5 % CO2. Transfection was 
performed as described above using the four fold among. 
2.2.8. Immunofluorescence of ST8SiaII variants in LMTK- cells 
48 h after transfection (see 2.2.7) cells were washed with PBS, fixed in 4 % 
paraformaldehyde for 20 min, and washed twice with PBS. Coverslips were blocked in 20 % 
horse serum in PBS for 30 min. Subsequently, polySia staining was performed with 5 µg/ml 
of primary monoclonal antibody 735 (Behring Werke Marburg) in 20 % horse serum. After 
washing three times with PBS, the cells were incubated for 30 min at RT with sheep anti-
mouse IgG-Cy3 (1:300, Sigma) in 20 % horse serum. The cells were washed thrice with PBS, 
and coverslips were mounted in vectashield (Vectashield) and analyzed under an Axiovert 
200 M fluorescence microscope (Zeiss). 
2.2.9. Recombinant expression of ST8SiaII Q3AS5EE in bacteria 
Transformation of bacteria 
50-100 µl of competent E .coli AD494(DE3) or Origami(DE3) were thawed on ice and 10 ng 
of plasmid DNA were added. The mix was placed for 10 min on ice. After a heat shock for 
40 sec at 42 °C, samples were incubated for another 10 min on ice. Subsequently, 300 µl of 
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LB medium were added and the bacterial culture was incubated at 37 °C. After 20-40 min the 
bacterial culture was plated on selective LB-agar plates containing the appropriate antibiotics. 
Expression of recombinant proteins in E. coli 
For bacterial expression of recombinant proteins the pET-vector system (Novagen) was used. 
30-500 ml cultures of E. coli strains Origami(DE3) or Ad494(DE3) transformed with the 
respective expression plasmids were grown in LB or power broth (PB) medium containing 
selective antibiotics at appropriate temperature and 300 rpm to an optical density of OD600nm= 
0.6 for LB or OD600nm=1.2 for PB medium. Subsequently, the expression of the recombinant 
protein was induced with 0.1 mM or 1 mM isopropyl-1-thio-ß-D-galactopyranoside (IPTG) 
for 3 h at 30°C or 24 h at 15 °C. Cells were harvested by centrifugation (15 min, 6,000xg, 
4°C). The bacterial pellet was stored at -20°C. 
Preparation of soluble and insoluble E. coli fractions: 
For analytical preparation bacterial pellets obtained from 1 ml of expression culture were 
resuspended in 100 µl TE buffer (10 mM Tris-HCl, pH 8.0; 1 mM EDTA) containing 10 µg 
of lysozyme and the samples were incubated for 15 min at 37°C. After sonication in a beaker 
resonator (Branson, 100 % duty cycle, output control 5) for 2 min at 4°C the soluble 
(supernatant) and insoluble fractions (pellet) were separated by centrifugation (15 min, 
11,000xg, 4°C). Soluble and insoluble fractions were analyzed by 10 % SDS-PAGE followed 
by western blot analysis and coomassie staining (2.2.16/17). 
For large scale preparation, the bacterial pellet obtained from 500 ml expression culture was 
resuspended in 5 ml buffer A (MBP-ST8SiaII Q3AS5EE: 20 mM Tris/HCl pH 7.5; 25 mM 
NaCl or NusA-Strep-ST8SiaII Q3AS5EE: 100 mM Tris/HCl pH8.0; 150 mM NaCl) and 
supplemented with protease inhibitors (40 µg/ml Bestatin; 1 mM PMSF; 0.5 µg/ml 
Leupeptin; 1 µg/ml Pepstatin). Bacteria were lysed by sonication with a microtip (Branson 
Sonifier, 50 % duty cycle, output control 5, 4°C) using eight pulses of 30 s intermitted by 
breaks of 30 s. Cell debris were removed by centrifugation (15 min, 20,000xg, 4°C).  
Resulting supernatant containing MBP-ST8SiaII Q3AS5EE was directly coupled to the 
equilibrated amylose resin (NewEnglandBiolabs), whereas the supernatant containing NusA-
Strep-ST8SiaII Q3AS5EE was additionally supplemented with 20 µg/ml avidin (IBA) and 
incubated for 30 min at 4°C. After centrifugation (15 min, 12,000xg, 4°C) supernatant was 
filtered (0.8 µm cellulose acetate filter; Sartorius) and applied on equilibrated strep-tactin 
matrix (IBA).  
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2.2.10. NusA-Strep-purification of ST8SiaII Q3AS5EE 
Supernatant obtained as described in 2.2.9. was applied on 250 µl strep-tactin matrix (IBA). 
Subsequently, the matrix was washed with 30 column volumes (CV) of buffer A (100 mM 
Tris/HCl pH 8.0; 150 mM NaCl). The protein was eluted with 5 CV of buffer E (buffer A 
containing 2.5 mM desthiobiotin). Protein containing fractions were analyzed by SDS-PAGE 
followed by western blot analysis and coomassie staining (2.2.16/17). PolyST containing 
fractions were concentrated in a vivaspin concentrator (10,000 MVCO PES; Vivascience), 
quick-frozen in liquid nitrogen and stored at -80°C. 
2.2.11. Maltose-Binding-Protein (MBP)-purification of ST8SiaII Q3AS5EE 
Supernatant obtained as described in 2.2.9. was incubated with 1 ml of amylose resin 
(NewEnglandBiolabs) for 1 h at 4 °C and for further washing packed into a column. The 
column was washed with 15 column volumes of buffer A (20 mM Tris/HCl pH 7.5; 25 mM 
NaCl) with a flow rate of 0.5 ml/min and protein eluted with buffer B (buffer A containing 
10 mM maltose). 1 ml fractions were collected and protein containing fractions were 
analyzed by SDS-PAGE followed by western blot analysis and coomassie staining 
(2.2.16/17). PolyST containing fractions were concentrated in a vivaspin concentrator 
(10,000 MVCO PES; Vivascience), quick-frozen in liquid nitrogen, and stored at -80°C or 
further analyzed by size-exclusion chromatography. 
2.2.12. Size-exclusion chromatography 
A Superdex 200 HR 10/30 column (Amersham Biosciences) was equilibrated in degassed 
and 0.22 µm sterile filtrated buffer T (MBP-ST8SiaII Q3AS5EE: 50 mM Tris/HCl pH 7.5; 
300 mM NaCl)  using the Äkta FPLC system (GE Healthcare). Purified protein was applied 
and eluted in 0.5 ml fractions at a flow rate of 0.5 ml/min. Polysialyltransferase containing 
fractions were concentrated in a vivaspin concentrator (10,000 MVCO PES; Vivascience) 
and stored at -80°C after quick-freezing in liquid nitrogen. 
2.2.13. mST8SiaII S3AS5EE expression and purification from insect cells 
Recombinant baculoviruses were generated based on transposon-mediated recombination in 
E. coli DH10Bac cells using the Bac-to-Bac Baculovirus Expression System (Invitrogen). 
Preparation of recombinant bacmid DNA: 
100 µl of competent E. coli DH10Bac were thawed on ice and incubated for 30 min with 
20 ng of the respective pFastBac vector construct. The transformation mix was subjected to a 
heat shock at 42°C for 45 sec and incubated on ice for 2 min. 900 µl of SOC-medium were 
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added, the cell suspension was incubated at 37°C for 4 h before plated on selective LB-agar 
plates containing 50 µg/ml kanamycin, 7 µg/ml gentamicin, 10 µg/ml tetracycline and 
40 µg/ml IPTG. For blue-white screening 30 µl of X-Gal solution (20 mg/ml in DMSO) were 
spread on the plates prior to plating. Positive transformants were identified after 48 h 
incubation at 37°C as pure white colonies and re-streaked on fresh plates to confirm the 
phenotype. 5 ml LB-medium containing 50 µg/ml kanamycin, 7 µg/ml gentamicin and 
10 µg/ml tetracycline were inoculated with a positive colony and incubated overnight at 37°C 
and 300 rpm. Bacmid DNA was isolated using the “Concert High Purity Plasmid Purification 
System” (GibcoBRL) according to the manufactures instructions. 3 ml of bacterial culture 
were pelleted (1 min, 12,000xg, RT), resuspended in 400 µl buffer E1 and lysed for 5 min at 
RT after addition of 400 µl buffer E2. 400 µl neutralization buffer E3 was added, the samples 
were centrifuged (10 min, 12,000xg, RT) and the supernatant was applied to the concert HP 
columns, equilibrated in buffer E4. After washing two times with 2.5 ml buffer E5, bound 
bacmid DNA was eluted in 900 µl buffer E6. 630 µl of 2-propanol were added to the eluent 
and the DNA was pelleted (30 min, 20,000xg, 4°C). The pellet was washed with 1 ml of 70% 
ethanol and centrifugated (15 min, 20000xg, 4°C). The bacmid DNA was air-dried for 30 min 
and resolved in 50 µl of 5 mM Tris/HCl pH 8 for 2 h at RT and stored at 4°C.  
Production of recombinant baculoviruses and high-titer stocks: 
Baculoviruses were produced by transfecting the prepared recombinant bacmid DNA into Sf9 
cells. For transient transfection 1x106 cells were seeded per well of a six well tissue culture 
plate. Transfection mix was prepared from 5 µl of bacmid DNA and 6 µl Cellfectin 
(Invitrogen) in 100 µl of culture media each. Both dilutions were combined and incubated for 
30 min at RT. The medium was aspirated from adherend Sf9 cells and replaced with 
transfection mix diluted in 1 ml culture medium. The transfection mix was removed after 
14 h and replaced with 2 ml culture medium. The transfected cells were incubated at 27°C for 
4-7 days until signs of viral infection like enlarged cell diameters and a granular appearance 
of the cells were clearly visible. 
The supernatant (low-titer P1-stock) was harvested and stored at -80°C. For virus 
amplification 40 µl P1-stock were added to 4 ml Sf9 cells (0.5x106 cells/ml) in a 25 cm2 cell 
culture bottle (Sarsted) and incubated for 3-4 days (P2-stock). Further amplification of the 
baculovirus stock was performed by infecting 50 ml suspension culture (2x106 cells/ml) with 
50 µl of P2-stock. After three days, the cells were pelleted by centrifugation (5 min, 300xg, 
RT) and the supernatant was sterile filtered (0.2 µm cellulose acetate filter; Sartorius) and 
stored at 4°C (P3-stock).  
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Baculoviral expression of ST8SiaII variants in Sf9 cells: 
For baculoviral expression of recombinant mST8SiaIIS3ASEE5 log-phase Sf9 cells at a 
density of 1.5-2x106 cells/ml were infected with different concentrations of P3-stock and 
cultivated for time response at 27 °C and 90 rpm. Culture supernatants were assayed for 
protein expression by SDS-PAGE followed by western blot analysis (2.2.16). The dose of 
baculovirus required for optimal expression of recombinant protein was used for subsequent 
large scale expressions cultures. 
Purification of baculoviral expressed zST8SiaII variants from Sf9 cells: 
4 L-expression cultures were infected with the optimal baculovirus concentration and 
harvested at the time point determined previously. To harvest the expressed recombinant 
protein, cells were pelleted (10 min, 300xg, 4°C) and the supernatant was adjusted with 
NaOH to pH 7.5 and re-centrifugated (20 min, 7,000xg, 4°C). Subsequently, the supernatant 
was filtered (0.22 µM Millipore-1L-device) and concentrated to 200 ml (Ultrasette 
10,000 MWCO) at 4 °C. To remove low molecular weight inhibitors the concentrate was 
diluted 1:5 with buffer DT (50 mM Tris/HCl; 100 mM NaCl; pH 7.5) and concentrated to 
80 ml. Protein containing solution was filtered (0.22 µM) and 10 % glycerol was added. 
Coupling to Ni2+chelating matrix (Probond-resin; Invitrogen) was performed overnight at 
4°C. For all following steps Äkta FPLC (GE Healthcare) was used with a flow rate of 
1 ml/min. The protein was eluted stepwise starting with 25 mM imidazole in precooled buffer 
A (50 mM Tris/HCl pH 7.5; 150 mM NaCl; 10 % glycerol) followed by 80 mM imidazole 
and 400 mM imidazole in buffer A, respectively. 1 ml fractions were collected and protein 
containing fractions were analyzed with SDS-PAGE followed by western blot analysis and 
silver staining (2.2.11/12). Polysialyltransferase containing fractions were concentrated in a 
vivaspin concentrator (10,000 MVCO PES; Vivascience), quick-frozen in liquid nitrogen and 
stored at -80°C. 
2.2.14. Enzyme linked immunosorbent assay for polyST activity 
To monitor polyST activity in a non radioactive test system an enzyme-linked 
immunosorbent assay (ELISA) had previously been established by Dr. Stummeyer from our 
laboratory. Therefore, a 96 well microtiter plate (Greiner) was coated with 25 µl/well of 
10 µg/ml mouse IgG (Pierce) in PBS for 3 h at RT. After washing thrice with PBS plastic 
surface was blocked with 1 % BSA in PBS (Sigma) overnight at 4°C. For NCAM-
polysialylation 25 µl of 30 ng/ml polySia free proteinA-NCAM fusion protein was adsorbed 
for 1 h at RT. After washing three timeswith PBS and once with reaction buffer (10 mM 
MES, 10 mM MnCl2) 0.2 µg-1 µg polyST were directly incubated in reaction buffer, 
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containing 1 mM CMP-Neu5Ac and 3.3 % humans serum for 3 h at 27°C or overnight at RT. 
The plates were washed two times with PBS and subsequently incubated with 25 µl/well of 
biotinylated fab-fragments of mAb 735 (Davids Biotechnologie) diluted 1:500 in 1 % BSA 
(Sigma) for 1 h at RT. Afterwards, plates were washed three times with PBS. The bound 
biotinylated antibody was detected with streptavidin-horseradish peroxidase conjugate 
(Roche) using 20 µl of a 1:20,000 dilution per well. After 30 min at 37°C plates were washed 
three times with PBS and developed with 50 µl of substrate solution containing 5 µg 
3,3’,5,5’-tetramethylbenzidine (TMB), 100 mM sodium acetate, 100 mM citric acid, and 
0.0045 % H2O2. Reactions were stopped after 20 min by adding 25 µl 2 N H2SO4, and the 
optical density at 450 nm was measured in PowerWave 340 microtiter plate 
spectrophotometer (BioTek).  
2.2.15. In vitro assay for NCAM polysialylation 
For the in vitro NCAM-polysialylation assay polySia negative CHO-2A10 cells, defective in 
the ST8SiaIV gene (Gerardy-Schahn et al., 1995) were transfected as described in 2.2.7. To 
standardize the concentration of ProtA-ST8SiaII variants for the polysialylation assay, an 
enzyme-linked immunosorbent assay (ELISA) was used as described by Mühlenhoff et al. 
(2001).  
Round-bottom microtiter plates (Greiner) were coated overnight with 0.2 µg murine IgG 
(Pierce) at 4°C and blocked with bovine serum albumin (1 % in PBS) (Sigma) for 2 h at RT. 
Plates were washed with PBS prior to addition of 20 µl/well cell supernatant that contained 
ProtA-ST8SiaII variants. Plates were incubated for 1 h at RT to allow binding of ProtA- 
polyST fusion-variants to IgG. In parallel, serial dilutions (1 - 0.05 ng/ml) of the recombinant 
IgG-binding fragment of ProteinA (Sigma) were included to generate a standard curve. After 
the adsorption step, plates were washed three times with PBS, before adding 20 µl/well of 
biotinylated anti-ProteinA antibody in an 1:80,000 dilution (Sigma). The plates were 
incubated for 1 h at 37°C and washed three times with PBS. The bound biotinylated antibody 
was detected with streptavidin-horseradish peroxidase conjugate (Roche) using 20 µl/well of 
an 1:20,000 dilution. After 30 min at 37°C plates were washed three times with PBS and 
developed with 50 µl/well of substrate solution containing 5 µg 3,3’,5,5’-
tetramethylbenzidine (TMB), 100 mM sodium acetate, 100 mM citric acid, and 0.0045 % 
H2O2. The staining reaction was stopped after 20 min by adding 25 µl/well 2 N H2SO4, and 
the optical density at 450 nm was determined using a PowerWave 340 microtiter plate 
spectrophotometer (BioTek). All samples were measured in serial dilutions, and triple values 
were analyzed for each dilution. 
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PolyST activity was assayed by incorporation of [14C]-labeled sialic acid residues into a 
growing polySia chain and monitored by SDS-PAGE followed by autoradiography. 30 ng of 
recombinant polySia-free ProtA-NCAM was incubated with 20 µl of IgG-coated sepharose 
beads (Pierce) for 1 h at 4°C. After washing with PBS 1 µg of enzyme variants was added 
and incubated for 1 h at 4°C. Afterwards beads were washed three times with 1 ml PBS and 
two time with 1 ml reaction buffer (10 mM MES buffer pH 6.7; 10 mM MnCl2) and 
resuspended in 40 µl reaction buffer containing 0.12 mM (21 Bq/µl) [14C]-CMP-Neu5Ac 
(GE Healthcare). Samples were incubated at 37°C and 1300 rpm to allow enzyme reaction. 
After 4 h, the reactions were terminated by washing (two times with 1 ml PBS). As an assay 
control, one out of two parallel samples was treated with 20 µg/ml of the polySia-degrading 
enzyme EndoNF in a final volume of 50 µl PBS for 30 min at 37°C. After two additional 
washing steps with 1 ml PBS each, residual buffer was removed and 20 µl of 2xLaemmli 
loading buffer containing 2 % ß-mercaptoethanol were added. Samples were heated for 
10 min at 60°C and analyzed by SDS-PAGE followed by autoradiography (Mühlenhoff et al., 
2001).  
2.2.16. SDS-PAGE analysis and immunoblotting 
For protein separation a SDS-PAGE was performed according to Laemmli (Laemmli, 
Beguin, and Gujer-Kellenberger, 1970). SDS-PAGEs were composed of a 3 % stacking gel 
[125 mM Tris/HCl pH 6.8; 0.1 % SDS; 3 % polyacrylamide(40 % 4 K-Mix, AppliChem)] 
and a separating gel in a range of 7-14 % polyacrylamide [375 mM Tris/HCl pH 8.8; 0.1 % 
SDS; 7-14 % Acrylamide (40 % 4 K-Mix, AppliChem)]. After mixing all components 
polymerization was initiated by adding 0.1 % TEMED and 1 % ammonium persulphate. 
For sample preparation, the samples were diluted 1:1 with Laemmli buffer containing 2 % ß-
mercaptoethanol and boiled for 5 min or heated to 60°C for 10 min, if they contained heat-
sensitive polySia.  
Electrophoresis was performed in SDS-electrophoresis buffer (50 mM Tris; 350 mM glycine; 
0.1 % SDS) at 60 V for the stacking gel and at 140 V for the separating gel. 
After SDS-PAGE, separated proteins were transferred onto a nitrocellulose membrane 
(Schleicher & Schüll), using a semidry blotting chamber (Biometra) at 2 mA/cm2 for 45 min. 
Gel and membrane were placed between two layers of filter paper (Whatman) soaked in 
blotting buffer (48 mM Tris, 39 mM glycine). Western blots were developed using the 
recommended primary antibody concentration, followed by anti-mouse alkaline phosphatase 
conjugate (Dianova). Nitro blue tetrazolium (NBT) and 5-bromo-4-chloro-3- inodyl 
phosphate (BCIP) were used as substrates for alkaline phosphatase staining reaction. 
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2.2.17. Silver staining /coomassie staining 
Silver staining: 
After SDS-PAGE, protein bands were visualized by silver staining. Initially, the SDS-gel was 
incubated in fixation solution (10 % acetic acid; 30 % ethanol; 1.85 % formaldehyde) for 
20 min. After washing three times with 50 % ethanol for 20 min the gel was incubated for 
exactly 1 min in thiosulphate solution (20 mg thiosulphate in 20 ml H2O) and washed in 
deionised water for 40 seconds. Subsequently the gel was incubated in silver staining solution 
(0.2 % AgNO3; 2.8 % formaldehyde) for 20 min. After washing with deionised water the gel 
was incubated in developing solution (6 % NaCO3; 2 % (v/v) thiosulphate solution; 1.85 % 
formaldehyde) until the bands appeared. Staining was stopped by washing with water and 
stop solution (10 % acetic acid; 30 % ethanol). Before drying, the gel was incubated in 30 % 
ethanol for 30 min and subsequently in drying solution (10 % glycerol; 20 % ethanol) for 
20 min. Gels were dried in cellophane foil overnight at 50 °C. 
Coomassie staining: 
After SDS-PAGE, protein bands were stained by colloidal solution of Roti®-blue (Roth). In 
according to the manufactures instructions a staining solution was prepared in 20 % 
methanol. SDS-gels were incubated in staining solution overnight at RT and destained in 
25 % methanol.  
After incubation in drying buffer (10 % glycerol; 20 % ethanol) for 20 min at RT. Gels were 
dried in cellophane foil overnight at 50 °C. 
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2.3. Results  
 
 
 
2.3.1. Phylogenetic display of the N-glycosylation patterns in the polysialyltransferase 
ST8SiaII  
 
The eukaryotic polysialyltransferase (polyST) ST8SiaII is a member of the a2,8-
sialyltransferase protein family and therefore comprises all three conserved sialyl-motifs (S-
motif, L-motif and VS-motif). ST8SiaII contains six N-glycan attachment sites conserved 
over a wide range of species such as mouse, chicken and African clawed frog, (fig. 19 A).  
Mutational studies carried out with the murine enzyme (mST8SiaII) have demonstrated that 
enzymatic activity crucially depends on the presence of two out of six N-glycan attachment 
sites, N89 (#3) and N219 (#5) (Close et al., 2001; Mühlenhoff et al., 2001). 
Interestingly, the functional ST8SiaII isolated from zebrafish lacks the N-glycosylation site 
corresponding to N219 (#5) in mouse (Marx et al., 2007). A multip le sequence alignment 
carried out with MultAlin (Corpet, 1988) revealed that the bonefishes -zebrafish and 
pufferfish- comprise the conserved sequence SEE instead of the N-glycan attachment site 
(fig. 19 A). This offers the possibility to apply a method called SUNGA (substitution of N-
glycan functions in glycosyltransferases by specific amino acids) with the aim to substitute 
the N-glycan function (#5) in mST8SiaII by the bonefish sequence (Uemura et al., 2006). For 
ST8SiaII the method SUNGA is restricted to the N-glycosylation attachment site N219 (#5) 
as site N89 (#3) is conserved among all known polySTs.  
This study aims at generating a minimally or even non-glycosylated mST8SiaII variant by a 
directed engineering approach. 
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Figure 19: Multiple  sequence alignment and scheme of murine ST8SiaII. A. Multiple sequence 
alignment of different ST8SiaIIs was generated with MultAlin (Corpet, 1988). Sequence identity is 
highlighted in dark boxes and important N-glycosylation attachment sites N89 and N219 are 
indicated. B. Schematic representation of the murine polysialyltransferase ST8SiaII. Positioning of N-
glycosylation sites are given by the respective asparagine residues (N) whereupon sites required for 
polyST activity are marked by an asterisk. Sialyl-motifs (L, S and VS), polyST domain (PSTD) and 
conserved cysteine residues (C) are indicated The N-glycosylation pattern of wild-type ST8SiaII is 
depicted in the left panel, whereas a non-glycosylated variant is shown in the right panel. In the non-
glycosylated variant N-glycosylation sites 1,2,3,4 and 6 were removed by substitution of the 
respective asparagine residues by glutamine (NàQ) within the N-X-S/T consensus motifs. SUNGA 
was introduced on N-glycosylation site N219 (5) by exchanging the sequence VNAT found in the 
murine enzyme by the bonefish sequence ASEE.  
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2.3.2. Engineering of minimally glycosylated mST8SiaII  
 
In the following, a set of N-glycosylation depletion variants of mST8SiaII was generated with 
the final aim to obtain an active N-glycosylation free enzyme. Based on already existing data, 
the study could be started with a mST8SiaII variant, containing only two out of six N-glycan 
sites, the sites N89 (#3) and N219 (#5), known to be required for activity (Close et al., 2001; 
Mühlenhoff et al., 2001). N-glycosylation sites naturally occurring in the positions N60, N72, 
N134 and N234 were replaced by glutamine ((Q60 (#1), Q72 (#2), Q134 (#4) and Q234 (#6)) 
as shown in figure 19 B.  
In a first trial to create a non-glycosylated variant of mS T8SiaII we started from a mST8SiaII 
variant in which all N-glycan sequons had been replaced by exchange of asparagine to 
glutamine (N/Q). This construct termed mST8SiaII Q3Q5 was already existing in the 
laboratory as mST8SiaII?1-6 (Mühlenhoff et al., 2001). To apply the SUNGA strategy in the 
mST8SiaII Q3Q5 the sequence of the former N-gycan #5 (VQ5AT) was substituted by either 
the conserved bonefish sequence AS5EE, resulting in the variant mST8SiaII Q3AS5EE or 
modified by single substitution of Q5 to S5 (mS T8SiaII Q3S5). Glycosylation variants were 
transiently transfected in polySia-free LMTK- cells expressing NCAM and enzymatic activity 
was detected by polySia surface staining with polySia specific mab 735. Although reduced if 
compared to the wild type control, polySia staining could be clearly observed on cells 
transfected with mST8SiaII Q3AS5EE, indicating residual activity in the non-glycosylated 
variant (fig. 20 A).  
To our surprise we also found marginal polysialylation activity for mST8SiaII Q3S5. This 
variant carries only the exchange to serine whereas the neighboring amino acids were not 
modified to match the bonefish sequence (fig. 20 A and fig. 19 A). Additionally, comparison 
of two previous N-glycosylation depletion studies of ST8SiaII (Mühlenhoff et al., 2001; 
Close et al., 2001) suggested, that generally, substitution of the respective N-X-S/T 
asparagine residues to serine appears to be more favorable for enzyme activity than 
substitutions to glutamine. Therefore we analyzed enzyme variants mST8SiaII Q3N5 and 
mST8SiaII S3N5 as depicted in figure 20 A. This direct comparison revealed that the serine 
variant is indeed more active. Therefore we hypothesized that enzymatic activity of the N-
glycan-free polyST-variants ST8SiaII Q3AS5EE and ST8SiaII Q3S5 might be enhanced, if a 
serine-residue is introduced instead of a glutamine at N-glycosylation site N89 (#3). As 
shown in figure 20 this hypothesis proved to be correct because slightly enhanced intensities 
of polySia surface staining was found for mST8SiaII S3AS5EE and mST8SiaII S3S5. A single 
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serine substitution at N-glycosylation site 3 (mST8SiaII S3Q5) was, however, not enough to 
restore activity (fig. 20 A).  
 
Figure 20: Polysialylation activity of N-glycosylation variants of full-length mST8SiaII. N-
terminally Flag-tagged wild-type and N-glycosylation variants of mST8SiaII were transiently 
expressed in the presence or absence of NCAM in polySia free LMTK- cells. 48 h post transfection, 
cells were fixed with paraformaldehyde and polySia surface was stained using mAb 735. Cell staining 
was visualized at 630-fold magnification. A. PolySia staining in the presence of stable transfected 
NCAM. B. PolySia staining in the absence of NCAM. 
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Transient transfection in polySia-free LMTK- cells was repeated for all mST8SiaII variants 
described above, but in the absence of the polySia-acceptor NCAM (fig. 20 B). This study 
was carried out to detect autopolysialylation, whereupon no polySia staining was expected 
for all N-glycan-free mST8SiaII variants due to the lack of acceptor sites. Fully unexpected, 
faint polySia staining occurred in the absence of NCAM with all N-glycan-free mST8SiaII 
variants that were shown to be competent in NCAM-polysialylation before (fig. 20 A+B).  
Although at this point the presence of a second endogenous polySia acceptor in LMTK- cells 
cannot be excluded, a second possibility to explain this effect might be that polySia is 
artificially attached to O-glycosylation sites in the active enzyme if there are no N-glycan 
acceptors present. Of particular importance is the fact, that potential O-glycan attachment 
sites were inserted in all active N-glycan-free mST8SiaII variants by the introduction of 
serine residues. To exclude the latter possibility, we analyzed the additional N-glycan-free 
variant  mST8SiaII Q3AM5EE lacking artificial serine residues. The variant was shown to be 
functionally active in LMTK- cells in the presence of NCAM (fig. 21 A). By contrast, no 
polysialylation activity was detectable with mST8SiaII Q3AM5EE in the absence of the 
polySia acceptor NCAM (fig. 21 B). This result indicates that artificial O-glycans attached to 
S5 serve as polySia acceptor and simultaneously argues against the presence of an additional 
endogenous polySia acceptor in LMTK- cells. Moreover, clone ST8SiaII Q3AM5EE also 
evidences that NCAM-polysialylation competence in polySTs is not essentially dependent on 
the glycosylation (N- or O-glycans) of the protein.  
 
 
Figure 21: Polysialylation activity of a non-glycosylated variant of full-length mST8SiaII. N-
terminally Flag-tagged non-glycosylated variant of mST8SiaII was transiently expressed in the 
presence or absence of NCAM in polySia free LMTK- cells. 48 h post transfection, cells were fixed 
with paraformaldehyde and polySia surface was stained using mAb 735. Cell staining was visualized 
at 630-fold magnification. A. PolySia staining in the presence of NCAM. B. PolySia staining in 
LMTK- cells transfected with the polyST variants in the absence of NCAM. 
 
To control if functionality of mST8SiaII variants as described above can be preserved also in 
soluble protein forms, we exemplarily analyzed the construct mST8SiaIIDN31-S3AS5EE in 
LMTK- cells as described above. Due to the use of the Ig?  leader sequence for secretion, this 
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protein should be released to the culture medium. To facilitate protein detection and 
enrichment, a C-terminal Myc/His-tag was added. As depicted in figure 22, NCAM-
polysialylation capacity was preserved also in the soluble enzyme variant. 
 
 
Figure 22: Polysialylation activity of a non-glycosylated variant of secreted mST8SiaII?31. N-
terminally truncated and C-terminally Myc-His tagged mST8SiaII variants were transiently expressed 
in the presence of NCAM in polySia free LMTK- cells. 48 h post transfection, cells were fixed with 
paraformaldehyde and polySia surface was stained using mAb 735. Cell staining was visualized at 
630-fold magnification.  
 
Taken together, the SUNGA allowed us for the first time the generation of a non-
glycosylated but active mST8SiaII variant. Because the protein was found to be active in the 
full- length and N-terminally truncated form, the clone with highest activity mST8SiaII-
Q3AS5EE was chosen for soluble expression in bacteria.  
 
 
2.3.3. Recombinant expression of mST8SiaII Q3AS5EE in bacteria 
 
Based on our finding that various N-glycan-free mST8SiaII variants maintained enzymatic 
activity, we chose one of them for recombinant expression in bacteria. It has to be taken into 
account that polySTs comprise two essential disulfide bonds that are usually not formed in 
bacteria. Fortunately, there are some engineered bacterial strains such as E. coli Ad494(DE3) 
and Origami(DE3) available that promote disulfide bond formation. The construct 
mST8SiaII Q3AS5EE was cloned in various bacterial vectors harboring different tags or 
fusion proteins for purification. Recombinant expression of these ST8SiaII Q3AS5EE variants 
was tested in E. coli Ad494(DE3) and origami(DE3) under different conditions. The best 
conditions for the four tested constructs are shown in figure 23 A. Pellets of expression 
cultures were lysed by sonication and the insoluble (I) as well as the soluble (S) fractions 
were analyzed by 10 % SDS-PAGE followed by western blot analysis and coomassie staining 
(fig. 23 B). All mST8SiaII Q3AS5EE variants were mainly found in the insoluble fraction, 
nonetheless significant amounts of soluble protein were achievable with enzyme variants that 
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contain an N-terminal fusion protein (NusA or maltose binding protein (MBP)). By contrast, 
only a marginal quantity was produced of the N-terminally Strep-tagged 
mST8SiaII Q3AS5EE and soluble C-terminally His-tagged enzyme was not detectable 
(fig. 23 B). 
 
Figure 23: Expression of mST8SiaII Q3AS5EE in bacteria. All variants were expressed in the 
bacterial E. coli strains Ad494 and Origami assisting development of disulfide bonds. A.  Optimized 
condition for all four different mST8SiaII Q3AS5EE variants are listed. LB: lysogeny broth-medium, 
PB: PowerBroth-medium. B. Insolube (I) and solube (S) fractions were prepared and analyzed by 
SDS-PAGE followed by western blot analysis and coomassie staining. For western blotting antibodies 
directed against the respective tags were used. mST8SiaII variants are marked with arrows.  
 
 
2.3.4. Purification of ST8SiaII Q3AS5EE fusion proteins from bacteria 
 
As soluble expression of NusA- and MBP-fusion proteins of mST8SiaII Q3AS5EE was 
detectable, we hypothesized that parts of the protein are properly folded enzyme variants. 
Consequently, a trial was undertaken to purify NusA-ST8SiaII Q3AS5EE and MBP-
ST8SiaII Q3AS5EE from 500 ml bacterial culture. The NusA-ST8SiaII Q3AS5EE variant was 
enriched via the added Strep-tag II using strepTactin sepharose and MBP-ST8SiaII Q3AS5EE 
was purified by the amylose-resin system. Isolated enzymes were analyzed by 10 % SDS-
PAGE followed by coomassie staining (fig. 24, lower panel) and western blot analysis 
(fig. 24, upper panel). Significant expression of the NusA-fused enzyme variant was 
detectable in the crude lysate (Apply) but binding to StrepTactin sepharose was barely 
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detectable. The protein thus remained in the flow through (fig. 24 A). By contrast, large 
quantities of the MBP-fused mST8SiaII Q3AS5EE variant could be enriched using the 
amylose-resin system, although several C-terminal degradation products are visible in the 
coomassie staining as well as in the western blot (fig. 24 B). Enzymatic activity of the two 
mST8SiaII Q3AS5EE variants enriched from bacterial expression cultures was analyzed in an 
ELISA based activity assay. Therefore purified enzymes were incubated in the presence of 
30 pg of ProtA-NCAM adsorbed to a well of a 96 microtiter plate and reaction buffer 
containing 1 or 5 mM CMP-Neu5Ac. As a positive control we used the N-glycosylated form 
of mST8SiaII?N31 that was purified from Sf9 insect cells. As indicated in the Table added to 
figure 24, no activity was detectable for MBP-ST8SiaII Q3AS5EE and NusA-
ST8SiaII Q3AS5EE fusion protein. 
 
 
Figure 24: Purification of mST8SiaII Q3AS5EE variants from 500 ml bacteria culture. Bacteria 
were lysed by sonication and coupled for 2 h to the corresponding matrix for purification. Protein was 
eluted stepwise and peak fractions were analyzed with 10 % SDS-PAGE followed by western blot 
analysis and coomassie staining. PolyST containing fractions were incubated with reaction buffer 
(10 mM sodium cacodylate buffer pH 6.7; 10 mM MnCl2) containing 1 or 5 mM CMP-Neu5Ac and 
30 pg NCAM adsorbed to an IgG-coated microtiter plate overnight at RT. A. Purification of NusA-
Strep-ST8SiaII Q3AS5EE B. Purification of MBP-ST8SiaII Q3AS5EE. C. ELISA based activity assay 
for NCAM-polysialylation. 
 
Taken together, we could enrich MBP-ST8SiaII Q3AS5EE from bacterial expression cultures 
with a final yield of up to 0.6 mg/L, however, activity was not detectable for the purified 
enzyme.  
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2.3.5. Size-exclusion chromatography of bacterial expressed MBP-ST8SiaII Q3AS5EE  
 
To trace the molecular reasons for the loss of activity in bacterial expressed MBP-
ST8SiaII Q3AS5EE the quaternary organization of the isolated enzyme was analyzed by size-
exclusion chromatography using a superdex 200 column. The elution profile is shown in 
figure 25 A. Protein containing peak fractions were analyzed by SDS-PAGE followed by 
silver staining and western blot analysis using StrepTactin-AP to prove the presence of MBP-
ST8SiaII Q3AS5EE (fig. 25 B). This experiment clearly revealed that MBP-
ST8SiaII Q3AS5EE is eluted in the void volume and thus indicates the formation of high-
molecular weight oligomers or aggregates that may prevent functionality. 
 
 
 
Figure 25: Size-exclusion chromatography of MBP-ST8SiaII Q3AS5EE. The purified MBP-
ST8SiaII Q3AS5EE was analyzed by size-exclusion chromatography using a Superdex 200 column. 
A. Elution profile of MBP-ST8SiaII Q3AS5EE. Void volume (V0) and retention volumes of standard 
proteins are indicated. Peak fractions are shaded in grey. B. Peak fractions were analyzed by 10 % 
SDS-PAGE followed by silver staining or western blotting using an anti-StrepTactin-AP antibody.  
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2.3.6. Recombinant Expression of N-glycan free mST8SiaII S3AS5EE in Sf9 cells 
 
In an alternative approach to obtain sufficient amounts of an N-glycan free polyST, the 
enzyme variant mST8SiaII S3AS5EE was investigated for expression in insect cells. A 
baculoviral based insect cell expression system (Gibco BRL) was established for the N-
terminally His-tagged construct lacking the first 31 amino acids. Due to an N-terminally 
located honey bee melittin signal the His-tagged mST8SiaII S3AS5EE variant was secreted 
into the cell culture medium. Supernatants of infected Sf9 cells were collected at different 
time points post infection, concentrated by trichloric acetic acid precipitation and analyzed by 
SDS-PAGE and western blotting. The time course of mST8SiaII S3AS5EE secretion is shown 
in figure 26 and demonstrates that the amount of expressed recombinant mST8SiaII S3AS5EE 
is barely detectable.  
 
Figure 26: Baculoviral expression of secreted mST8SiaII S3AS5EE variant in Sf9 cells. Analysis 
of time response data after baculoviral expression of mST8SiaII S3AS5EE in Sf9 cells. After 24, 48, 
72 and 96 h cell culture supernatants of infected Sf9-cells were analyzed by 10 % SDS-PAGE - 
directly (supernatant) and after trichloric acetic acid precipitation (1:40 concentrated) - followed by 
western blot analysis using an anti-penta-His antibody. mST8SiaII S3AS5EE variant is marked with an 
arrow (upper band). 
 
 
2.3.7. Purification of histidine tagged mST8SiaII S3AS5EE expressed in Sf9 cells 
 
Despite of the extremely low expression yield, a 4 L culture of Sf9 cells was infected and a 
trial was undertaken to purify the N-terminally His-tagged mST8SiaII S3AS5EE from the 
supernatant, harvested 48 h post baculoviral infection. After volume reduction to 100 ml the 
recombinant protein was purified by Ni2+-NTA-beads. Eluted fractions were analyzed by 
10 % SDS-PAGE followed by silver staining and western blot analysis (fig. 27 A). Although, 
the enzyme variant mST8SiaII S3AS5EE was detectable by western blotting the respective 
silver stain revealed mainly impurities (fig. 27 A). Nevertheless a testing for enzymatic 
activity was undertaken using the ELISA based polysialylation assay. Therefore, 36 pg/well 
of ProtA-NCAM were coupled to an IgG coated 96 well microtiter plate. Thereafter, 0.5 µg 
or 1.0 µg of purified His-ST8SiaII S3AS5EE were incubated in reaction buffer (10 mM 
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sodium cacodylate buffer pH 6.7; 10 mM MnCl2) containing 1 mM or 10 mM CMP-Neu5Ac 
overnight at room temperature. While activity observed for the positive control demonstrated 
integrity of the test system, the non-glycosylated enzyme variant was completely inactive.  
  
Figure 27: Purification of mST8SiaII S3AS5EE from Sf9 cells. A. N-terminally His-tagged 
mST8SiaII S3AS5EE variant was baculoviral expressed in Sf9 cells. 48 h post infection, secreted 
protein was harvested by concentrating cell culture supernatant and incubated overnight with Ni2+ -
NTA-beads. Protein was eluted stepwise with imidazole and peak fractions were analyzed by 10 % 
SDS-PAGE followed by silver staining and western blot analysis using anti-penta-His antibody. 
B. For NCAM-polysialylation an ELISA based approach was performed. ProtA-NCAM was coupled 
to an IgG coated 96-well plate and 0.3 µg of His-mST8SiaII?31 or 0.5 µg/1.0 µg of 
ST8SiaII S3AS5EE were incubated in reaction buffer (10 mM sodium cacodylate buffer pH 6.7; 
10 mM MnCl2) containing 1 mM or 10 mM CMP-Neu5Ac overnight at RT.  
 
 
2.3.8. PolySia staining of glycosylation depleted mST8SiaII?31 variants in vitro 
 
This low yield in the expression of recombinant mST8SiaII S3AS5EE in Sf9 cells prompted us 
to switch back to the mammalian cell system. Therefore, a set of N-glycosylation variants 
based on the construct mST8SiaII?31 was generated as N-terminal proteinA fusion variants 
and transiently expressed in CHO-2A10 cells, which, due to a mutation in the endogenous 
polyST gene are polySia negative. After 72 h, 1 µg of each enzyme was immobilized on IgG-
sepharose beads and incubated with 0.12 mM CMP-[14C]Neu5Ac in the presence of 30 ng 
ProtA-NCAM for 4 h at 37°C. Samples were separated by 7 % SDS-PAGE before and after 
treatment with the polySia-degrading enzyme endoneuraminidaseF (endoNF) and reaction 
products were visualized by autoradiography. Polysialylation activity is indicated by a broad 
radioactive smear that can be removed by endoNF treatment. Due to the fact that endoNF 
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does not degrade the last three sialic acid residues of a polySia chain, protein acceptors are 
visible due to the remaining [14C]-labeled sialic acids. Using this assay system we could 
investigate NCAM-polysialylation competence of the ProtA-ST8SiaII glycosylation variants, 
but again only the fully N-glycosylated ProtA-ST8SiaII generated detectable levels of NCAM 
polysialylation in vitro and in vivo (fig. 28 A; fig. 20 A). By contrast, while clearly active in 
vivo, no activity was found with the N-glycan free enzymes mST8SiaII Q3N5 and 
ST8SiaII Q3AS5EE in vitro (fig. 28 A; fig. 20 A). These findings were confirmed by 
analyzing all variants in the ELISA-based assay system described above (fig. 28 C, 2.3.7). 
Expression of all variants was analyzed by SDS-PAGE followed by western blot analysis 
using an antibody directed against the ProtA fusion part. Although semi-quantitative, the 
western blot clearly demonstrated drastically reduced expression levels for the N-glycan 
variants. The observed shift in molecular mass that is visible in the western blot is due to a 
decreased molecular weight of nearly 5 kDa per absent N-glycosylation site (fig. 28 B).  
 
Figure 28: In vitro activity of N-glycosylation site depleted variants of mST8SiaII. N-
glycosylation variants of N-terminally truncated mST8SiaII?N31 were transiently expressed as 
proteinA fusion constructs in CHO-2A10 cells. A. 36 ng of ProtA-NCAM were adsorbed to IgG-
Sepharose-beads containing 1 µg of proteinA-ST8SiaII variants. Reaction was performed in reaction 
buffer (10 mM sodium cacodylate buffer pH 6.7; 10 mM MnCl2) containing 0.25 mM CMP-[14C]-
Neu5Ac for 4 h at 37°C. Samples were separated by 10 % SDS-PAGE before (-) and after (+) 
treatment with EndoneuraminidaseF (EndoNF) and visualized by autoradiography. B. Loading 
control: Western blot analysis of 1 µg Sepharose immobilized proteinA-ST8SiaII variants. Samples 
were analyzed by 10 % SDS-PAGE followed by western blotting using an antibody directed against 
the proteinA part. C. In an ELISA based approach 36 pg protA-NCAM were coupled to IgG antibody 
to a 96-well plate and 0.1 µg of ProtA-ST8SiaII or 0.2 µg of ST8SiaII variants were incubated in 
reaction buffer (10 mM sodium cacodylate buffer pH 6.7; 10 mM MnCl2) containing 1 mM or 10 mM 
CMP-Neu5Ac overnight at RT. 
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The results shown above demonstrate that expression of N-glycan depleted polySTs is a 
major hurdle in eukaryotic cells. A reason for this may be misfolding of the protein in the 
absence of N-glycans which are major elements in the ER-quality control system. Further 
engineering steps are needed to increase solubility and to obtain more efficiently expressed 
protein.  
 
 
 
2.4. Discussion 
 
In vertebrates, the unique linear homopolymer polysialic acid (polySia) is composed of a2,8-
linked N-acetylneuraminic acid (Troy, 1992).  Biosynthesis of this carbohydrate is catalyzed 
by the polysialyltransferases (polySTs) ST8SiaII and ST8SiaIV, exclusively, as simultaneous 
deletion of both genes resulted in polySia-negative mice (Weinhold et al., 2005). Up to now, 
polysialylation was identified as posttranslational modification of only five proteins, 
whereupon the neural cell adhesion molecule (NCAM) is by far the most prevalent (Rothbard 
et al., 1982; Hildebrandt, Mühlenhoff, and Gerardy-Schahn, 2008). Additional acceptors are 
neuropilin-2 (Curreli et al., 2007), the scavenger receptor, CD36 found in human breast milk 
(Yabe et al., 2003) and the a-subunit of the voltage dependent sodium channel (Zuber et al., 
1992). Furthermore, modification of polySTs by polySia has been referred to as 
autopolysialylation (Mühlenhoff et al., 1996; Mühlenhoff et al., 2001). The rarity of this 
modification suggests the presence of specific protein-protein interactions between polySTs 
and their acceptor proteins, as recently rationalized by the identification of a polyST 
recognition site on NCAM (Close et al., 2003; Mendiratta et al., 2005; Mendiratta et al., 
2006; Colley, 2008). Although polysialylation is limited to a few specific protein carriers, this 
modification was identified on N-glycans as well as O-glycans.  
Detailed in vitro analyses are required to further investigate structure-function relationships 
in eukaryotic polySTs. Unfortunately, the complex tertiary organization of these type-II-
transmembrane glycoproteins that involve two essential disulfide bonds and up to six partly 
polysialylated N-glycans impedes the development of straight forward approaches for the 
purification of polyST. This is particularly true, because integrity of the N-glycan attachment 
sites N89 (#3) and N219 (#5) of the mammalian enzymes is important for ST8SiaII activity 
(Mühlenhoff et al., 2001; Close et al., 2001). Nonetheless, a new method called SUNGA 
(substitution of N-glycan functions in glycosyltransferases by specific amino acids) recently  
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allowed engineering of a functional, non-glycosylated monosialyltransferase ST3Gal-V, 
although this enzyme is usually dependent on the presence of three N-glycans (Uemura et al., 
2006). Based on this result, we were interested in engineering a non-glycosylated polyST, as 
an N-glycan free enzyme harbors significant advantages. For instance, the lack of N-glycans 
would circumvent the necessity of a cost- intensive and time-consuming N-glycosylation 
competent expression system and allow recombinant expression using the more convenient 
bacterial system. Moreover, purification of the more homogeneous non-glycosylated polyST 
variant should be more suitable for protein crystallization than a heavily glycosylated 
enzyme.  
To engineer a non-glycosylated murine ST8SiaII (mST8SiaII), we generated several enzyme 
variants that differ exclusively in the constitution of N-glycosylation sites N89 (#3) and N219 
(#5) as indicated. All these mST8SiaII variants lack in addition the N-glycosylation sites #1, 
#2, #4 and #6 as they were found to be of minor importance with regard to activity 
(Mühlenhoff et al., 2001; Close et al., 2001). The respective asparagine residues in the N-X-
S/T consensus motifs are substituted by glutamine. So far, the attempt to generate a non-
glycosylated mST8SiaII variant failed, as deletion of all six N-glycosylation sites by 
substitution of the respective asparagine residues by glutamine, resulted in the inactive 
enzyme mST8SiaII Q3Q5 (Mühlenhoff et al., 2001). In the present study, multiple sequence 
alignment of various ST8SiaII homologues revealed that one out of the two essential N-
glycosylation attachment sites in the mST8SiaII is suitable to implement SUNGA. 
Consequently, we exchanged the sequence of N-glycosylation site N219 (#5) of mST8SiaII 
(VN5AT) by the conserved sequence AS5EE, found at the equivalent position in bonefish 
homologues (fig. 19). The resulting variant mST8SiaII Q3AS5EE maintained enzymatic 
activity as demonstrated by polySia surface immunofluorescence staining of transiently 
transfected LMTK- (polySia-/NCAM+) cells (fig. 20 A). Although polysialylation activity of 
mST8SiaII Q3AS5EE is drastically reduced compared to the fully glycosylated wild-type 
enzyme. Nevertheless, this is the first demonstration that an N-glycan free mST8SiaII 
exhibits functional activity. Because the SUNGA substitution was not possible on N-
glycosylation site N89 (#3) - this site is conserved among all known polySTs - the trial to 
substitute this site was based on an earlier report showing that substitution of the asparagine 
residue in N-glycosylation sites by serine maintains higher levels of residual activity in 
polySTs (Mühlenhoff et al., 2001; Close et al., 2001). Indeed, this measure applied to site #3 
by generating the N-glycan free variant mST8SiaII S3AS5EE (fig. 20 A) considerably 
improved enzymatic activity. Because also SUNGA applied at position #5 introduced a serine 
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residue, we investigated further if the serine residue contained in the bonefish sequence 
AS5EE is the major cause for preserved enzymatic activity. Therefore, the enzyme variants 
mST8SiaII Q3S5 and mST8SiaII S3S5 were produced and analyzed. Both variants revealed, 
however, significantly reduced activity if compared to the SUNGA clone with the 
substitution AS5EE. This finding clearly highlighted the positive effect achieved by the 
SUNGA method. Nonetheless, our studies also confirm that serine substitutions cause less 
harm in the polyST than glutamine substitutions in the N-X-S/T sequon.  
Because enzymatic activity of N-glycan free variants in the first part of this study was 
analyzed in the presence of the polySia acceptor NCAM, it was a surprise that faint polySia 
surface staining was observed in the absence of NCAM (fig. 20 B). Two theories are 
conceivable to explain polysialylation activity of N-glycan free mST8SiaII variants in the 
absence of NCAM. On the one hand the presence of an endogenous and so far unknown 
polySia acceptor in the used LMTK- cells would perfectly explain residual polySia surface 
staining of cells transfected with non-glycosylated mST8SiaII variants. On the other hand, 
serine residues were inserted in all active N-glycan free mST8SiaII variants that might have 
resulted in artificial O-glycans serving as alternative polySia acceptors. Polysialylation has 
already been proven to occur on O-glycans of neuropilin-2 and the scavenger receptor CD36 
(Curreli et al., 2007; Yabe et al., 2003). To distinguish between the two theories, we analyzed 
the N-glycan free variant mST8SiaII Q3AM5EE which lacks artificial serine residues. 
Transient transfection of mST8SiaII Q3AM5EE in polySia-free LMTK- cells resulted in 
significant polySia surface staining in the presence of NCAM, demonstrating that this 
enzyme variant is active (fig. 21 A). By contrast, no polysialylation activity was detectable 
for ST8SiaII Q3AM5EE in the absence of NCAM, arguing for O-glycosylation due to the 
presence of serine rather than for an additional endogenous acceptor molecule in LMTK- cells 
(fig. 21 B). Nonetheless, the occurrence of O-glycans has to be investigated by e.g. mass 
spectrometry to unequivocally confirm this finding. 
To obtain sufficient amount of recombinant polyST for further studies, a mST8SiaII variant 
that allows soluble and homogenous expression would be advantageous. Therefore, we 
exemplarily truncated an N-glycan free mST8SiaII variant by the transmembrane domain 
(first 31 amino acids) and subcloned the construct into pSecTag vector, to express it as a 
secretory protein. Subsequent analysis of this mST8SiaII variant in LMTK- cells revealed that 
the enzyme maintained activity (fig. 22). In conclusion, engineering of an N-glycan free 
mST8SiaII variant that was proven functional in mammalian cell culture forms the basis for 
soluble expression of polyST in bacteria.  
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As mST8SiaII requires two essential disulfide bonds, we chose the engineered bacterial 
E. coli strains Ad494(DE3) and Origami(DE3) that promote disulfide bond formation and 
therefore allow efficient expression of eukaryotic enzymes harboring crucial disulfide 
bridges. To optimize bacterial expression of mST8SiaII Q3AS5EE we tested four constructs 
differing in their N-terminal tags or fusion protein parts with regard to expression strains, 
temperature, medium and concentration of the expression inducing reagent IPTG. Best 
expression efficiency was obtained for mST8SiaII Q3AS5EE variants harboring an N-terminal 
NusA- or MBP-fusion protein, whereas marginal or no soluble expression was achieved with 
His- or Strep-tagged enzyme variants (fig. 23 B). Large N-terminal solubility-enhancing 
fusion parts presumably assist folding of mST8SiaII Q3AS5EE and prevent immediate 
aggregation of the native proteins. Successful soluble expression of non-glycosylated 
mST8SiaII Q3AS5EE variants in bacteria enabled us to start purification of the eukaryotic 
polyST. A final yield of up to 0.6 mg/L purified MBP-mST8SiaII Q3AS5EE was obtained, 
whereas purification attempts of the NusA-variant failed (fig. 24). However, unfortunately, 
no enzymatic activity was detectable for the purified MBP-mST8SiaII Q3AS5EE in the 
ELISA-based assay system (fig. 24 C). To trace back the loss of activity in the purified MBP-
ST8SiaII Q3S5EE, we first investigated the oligomerization state of the enzyme. Size-
exclusion chromatography was used and MBP-ST8SiaII Q3AS5EE was eluted in the void 
volume, clearly demonstrating the formation of high-molecular weight oligomers or 
aggregates. Because the zebrafish ST8SiaII was shown in Chapter 1 (fig. 12) to be a 
monomeric enzyme we assume that formation of aggregates may prevent functionality. A 
possible reason for aggregate formation could be an insufficient competence of the used 
bacteria to allow formation of the two essential disulfide bonds.  
To investigate whether the lack of enzymatic activity originates from misfolded aggregates 
due to insufficient disulfide bond formation, we analyzed an N-glycan free mST8SiaII variant 
in a eukaryotic expression system. As the non-glycosylated enzyme variant 
mST8SiaII S3AS5EE maintained highest activity, this variant was chosen for expression in 
Sf9 insect cells. Initial experiments displayed minor expression efficiency resulting in a 
marginal yield of 100 µg/L purified enzyme (fig. 27 A). Nonetheless, NCAM-polysialylation 
competence of the purified enzyme was tested in the ELISA-based assay system, but no 
enzyme activity was detectable, although substrate concentrations were increased to 
compensate for a possibly increased Km value  of the non-glycosylated enzyme variant 
(fig. 27 B).  
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Finally we tried to verify NCAM-polysialylation activity of the non-glycosylated mST8SiaII 
variants in vitro and therefore generated ProtA-ST8SiaII variants for soluble expression in 
polySia deficient CHO-2A10 cells. Polysialylation ability of the ProtA-fusion constructs was 
analyzed in an in vitro assay as described previously (Mühlenhoff et al., 2001). No enzymatic 
activity was detectable for the engineered ProtA-ST8SiaII Q3AS5EE variant. Remarkably, no 
enzymatic activity was detectable as well for the ProtA-ST8SiaII Q3N5 and ProtA-
ST8SiaII Q3Q5 variants in vitro, which is consistent with the previous observations made by 
Dr. Mühlenhoff (Mühlenhoff et al., 2001). The same  results were obtained for ProtA-
ST8SiaII variants when tested in the ELISA based assay.  
 
In this study we succeeded for the first time in engineering a functional non-glycosylated 
murine ST8SiaII variant by implementing the SUNGA method. This progress facilitated 
soluble expression of recombinant polyST in the cost-effective bacterial system. Although 
enzymatic activity of non-glycosylated ST8SiaII variants could be demonstrated in cell-
culture experiments, activity could not be confirmed in vitro. In summary it can be stated, 
that the first soluble expression of a mammalian polyST in a glycan free form using bacterial 
and eukaryotic system can be regarded as success. However, additional effort is needed to 
establish conditions that allow expression and testing of the functional enzyme.  
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General Discussion 
 
The Polysialyltransferases (polySTs), ST8SiaII and ST8SiaIV, synthesize the homopolymer 
polysialic acid (polySia), a posttranslational modification of some O-and N-linked glycans in 
vertebrates. The knock-out of both polySTs in mice demonstrates the crucial impact of 
polySia on life and survival. The absence of ST8SiaII in mice caused morphological changes 
in brain structures and altered fear conditioning (Angata et al., 2004), whereas the loss of 
ST8SiaIV resulted in reduced learning and memory in adult mice (Eckhardt et al., 2000). The 
knock-out of both polySTs led to a complete loss of polySia and caused drastic growth 
retardation in the early postnatal phase. More than 80 % of these mice died during the first 
four weeks after birth (Weinhold et al., 2005; Angata et al., 2007).  
In adults, the external addition of polySia in nerve deletion sites promotes nerve regeneration 
(El Maarouf and Rutishauser, 2008) by contrast the re-expression of polySTs in tumors 
(mainly ST8SiaII), enhances metastasis and impairs the actuarial survival rate of patients 
(Tanaka et al., 2001). Therefore, the controlled expression or inhibition of the polySia 
synthesizing polySTs is of emerging importance.  
Although the mammalian polySTs were cloned 13 years ago, there is still little known about 
the biochemical properties and the structure-function relationships of these important 
enzymes. 
The detailed analysis of structure-function relationships in polySTs is mainly hampered by 
the lack of expression systems capable to supply sufficient amounts of active enzymes. The 
two polySTs - ST8SiaII and ST8SiaIV - are transmembrane type II glycoproteins containing 
six and five N-glycan attachment sites, respectively.  The integrity of the N-glycan attachment 
sites N89 and N219 for ST8SiaII as well as N74 for ST8SiaIV is important for enzymatic 
activity (Mühlenhoff et al., 2001; Close et al., 2001). Furthermore, the polySTs comprise two 
essential disulfide bonds posing an additional challenge on recombinant expression and 
purification of these enzymes. Thus, expression of the eukaryotic polySTs is restricted to N-
glycan competent expression systems that ensure the formation of disulfide bonds. Although, 
mammalian and insect cell expression systems fulfill these requirements, they bear the 
problem of low yields of recombinant protein.  
Here, we were interested in establishing high yield expression systems to obtain sufficient 
amounts of recombinant enzyme for ligand binding studies and crystallization approaches to 
gain information about the catalytic mechanism of eukaryotic polySTs. In the present study 
we followed two different strategies to establish high yield expression systems of 
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recombinant active ST8SiaII. The aim of the first part of this work was to express and 
analyze ST8SiaII from the lower vertebrate zebrafish that lacks one out of the two N-
glycosylation sites that are important for polyST activity (Marx et al., 2007; Mühlenhoff et 
al., 2001; Close et al., 2001). In the second part, we started to engineer the murine ST8SiaII 
(mST8SiaII) to a non-glycosylated ST8SiaII variant for expression in the cost-efficient and 
timesaving bacterial expression systems.  
In this study we were focused on the N-glycan functions and their influence on ST8SiaII 
activity and expression. The mST8SiaII variant lacking the 3rd N-glycosylation site were 
already found to exhibit decreased activity as well as decreased expression levels and 
increased degradation in comparison to the fully glycosylated wild-type enzyme or variants 
lacking another N-glycan function (Dr. Mühlenhoff, personal communication). In the present 
study we could confirm these findings for zST8SiaII variants lacking the 3rd N-glycan 
attachment site (1.3.3). 
Interestingly, only for ST8SiaII from higher vertebrates another conserved N-glycosylation 
attachment site (N219) was reported to be important for enzymatic activity (Mühlenhoff et 
al., 2001; Close et al., 2001). Remarkably, the lower vertebrates zebrafish and pufferfish, do 
not comprise a corresponding 5th N-glycosylation attachment site, whereupon enzymatic 
activity is maintained (Marx et al., 2007). Therefore we suggest that the 5th N-glycosylation 
site of higher vertebrates might have gained an additional and so far unknown function in the 
course of evolution. That would explain the dramatic loss of enzymatic activity whenever this 
N-glycan attachment site is affected by amino acid substitutions. For instance, the N-glycan 
free mST8SiaII variant, obtained by substituting all respective asparagine residues located in 
a  N-X-S/T consensus motifs by glutamine (mST8SiaII Q3Q5), was found to be devoid of 
activity (fig. 20; Mühlenhoff et al., 2001). Remarkably, we could engineer an N-glycan free 
mST8SiaII variant that maintained residual activity by substitution of the 5th N-glycosylation 
site by conserved amino acids located at the equivalent position of the pufferfish ST8SiaII 
homologue. This method is called SUNGA and enables the investigation of evolutionary 
effects of N-glycan functions (Uemura et al., 2006). Therefore, we generated a set of N-
glycosylation depletion variants to further analyze the impact of the 5th N-glycosylation site 
of mST8SiaII with regard to enzymatic activity and expression efficiency of recombinant 
enzyme. The resulting non-glycosylated mST8SiaII variants ST8SiaII Q/S3S5, 
ST8SiaII Q/S3AS5EE and ST8SiaII Q/S3AM5EE, but not the ST8SiaII Q/S3Q5 variants 
catalyzed NCAM-polysialylation in LMTK- (polySia-/NCAM+) cells as visualized by polySia 
surface staining. Unexpectedly, the serine-containing N-glycan free enzyme variants 
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(ST8SiaII Q/S3S5, ST8SiaII Q/S3AS5EE) maintained polySia surface staining in the absence 
of the polySia acceptor NCAM. A suitable explanation for polySia surface staining in the 
absence of NCAM would be the presence of a so far unknown endogenous polySia acceptor 
in LMTK- cells. Although we can not exclude that the inserted serine residues might have 
resulted in artificial O-glycans serving as alternative polySia acceptors. Taken together, we 
could confirm the major impact of the 5th N-glycosylation site on mST8SiaII activity, 
although we could not discover the function of this site in mammalian polySTs (Mühlenhoff 
et al., 2001; Close et al., 2001). 
The major goal of the present study was to produce high amounts of homogenous and 
functional recombinant ST8SiaII to facilitate analyses of structure-function relationships and 
crystallization approaches. Two different strategies were adapted for this demand.  
On the one hand we succeeded in generating the functional N-glycan free enzyme variant 
mST8SiaII Q/S3AS5EE, that enabled us for the first time to achieve soluble expression in a 
bacterial expression system and subsequent purification of the recombinant enzyme. 
However, so far we could not demonstrate enzymatic activity of the purified mST8SiaII 
variant, what might be explicable with the formation of aggregates as found by size-exclusion 
chromatography. Further studies are required to obtain functional mST8SiaII using the 
bacterial expression systems. Possible starting points might be co-expression of mST8SiaII 
with chaperones (Uemura et al., 2006) or renaturation of purified enzyme in vitro (Saribas et 
al., 2007).  
In addition we could demonstrate that ST8SiaII from zebrafish (zST8SiaII) - in contrast to all 
homologous enzymes from higher vertebrates - lacks one out of the two N-glycosylation sites 
that are important for polyST activity, whereupon the zebrafish enzyme maintains activity 
(Marx et al., 2007). Using zST8SiaII we succeeded in expression and purification of 
recombinant enzyme from insect cells in high yields. This progress enabled us for the first 
time to start a detailed biochemical characterization of a eukaryotic ST8SiaII. Interestingly, 
zST8SiaII was found as a monomer by size-exclusion chromatography, suggesting a 
monomer as the catalytically active unit. By contrast, the prokaryotic polySTs were shown to 
assemble into high-order oligomers (Freiberger et al., 2007). Remarkably, eukaryotic and 
prokaryotic polySTs reveal no sequence similarities neither on DNA- nor on amino acid 
level. 
Furthermore, we established a STD-NMR spectroscopy based ligand epitope mapping for the 
zST8SiaII?N86. For the first time we could demonstrate that binding of the activated sugar 
CMP-Neu5Ac towards the enzyme is mainly mediated by the nucleotide moiety CMP. 
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Moreover, by analyzing binding properties of sialic acid oligomers towards zST8SiaII we 
could show that at least six a2,8-linked sialic residues of polySia are in close proximity to the 
enzyme’s surface. Furthermore, by monitoring the enzymatic reaction of zST8SiaII?N86 
using 1H-NMR-spectroscopy, we could detect product formation in the presence of the 
artificial acceptor Neu5Ac2Me, a sialic acid monomer in a fixed a-configuration.  This 
finding suggests a monomer as the minimal acceptor for polyST chain initiation and 
elongation.  
Moreover, this assay system (STD-NMR-spectroscopy in combination with activity assays 
based on 1H-NMR-spectroscopy) provides the vantage point for future studies to analyze the 
binding site in detail and to design inhibitors for polySTs (von Itzstein, 2007). The selective 
inhibition of ST8SiaII represents a promising target for cancer therapy. Although ST8SiaII 
and ST8SiaIV are highly homologous and catalyze the equivalent reaction on the same 
acceptors, only ST8SiaII showed reduced NCAM-polysialylation competence, if the 
unnatural sialic acid precursor N-butanoylmannosamine (ManNBut) was supplemented in 
cell culture (Bork et al., 2007). A specifically designed inhibitor against ST8SiaII, re-
expressed in tumors, might therefore have less adverse effects in therapy, since ST8SiaIV is 
the prominent polyST in adults. 
To gain more information about the catalytically active unit and the catalytic mechanism of 
ST8SiaII, we were interested to solve the three-dimensional structure by protein 
crystallization. For protein crystallization, a homogeneously expressed protein increases the 
prospect of success. The zST8SiaII?N86 could be purified in high quality from insect cells 
and initial precrystalls were obtained, however the remaining N-glycosylation sites might 
have interfered with the crystallization process and consequently impeded the formation of 
high quality crystals. Therefore, future studies to optimize bacterial expression and 
subsequent purification of the N-glycan-free mST8SiaII Q3AS5EE enzyme variant would be 
promising.  
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Appendix 1 – Abbreviations 
 
aa      Amino acid 
AP     Alkaline phosphatase 
BCIP     5-bromo-4-chloro-3-inodyl phosphate 
BDNF     Brain-derived neurotrophic factor 
BSA     Bovine serum albumin 
C     Cysteine 
CMP     Cytidine 5`-monophosphate 
C-terminal    Carboxy-terminal 
CTP     Cytidine 5`-triphosphate 
DMEM    ‘Dulbecco`s Modified Eage`s medium’ 
? N     N-terminal truncation of x aa 
DNA     Desoxyribonucle ic acid 
Dp     Degree of polymerization 
ELISA     Enzyme linked immuno sorbant assay 
EndoNF    Endoneuraminidase F 
ER     endoplasmatic reticulum 
FGFR     Fibroblast growth factor receptor 
FN     Fibronectin 
Gal     Galactose 
GFRa      Glial-derived neurotrophic factor receptor a 
kDa     kilo Dalton 
KM     Michaelis-Menten-Konstante 
LTP     Long-term potentiation 
IPTG     Isopropyl-beta-D-thiogalactopyranoside 
mAB     monoclonal antibody 
m     murine (mouse) 
Me     beta-Mercaptoethanol 
MBP     Maltose binding protein 
MES     2-(N-morpholino)ethanesulfonic acid 
N     Asparagine 
NBT     Nitro blue tetrazolium 
NCAM    Neural cell adhesion molecule 
Neu5Ac    5-N-acetyl-neuraminic acid 
NMR-Spectroscopy   Nuclear magnetic resonance spectroscopy 
N-terminal    Amino-terminal 
OD     Optical density 
PAGE     Polyacrylamide gel electrophoresis 
PBS     Phosphate buffered saline 
PCR     Polymerase chain reaction 
PMSF     Phenylmethansulfonylfluoride 
PolySia    Polysialic acid 
PolyST    Polysialyltransferase 
PPi     Pyrophosphate 
ProtA     ProteinA 
Q     Glutaminic acid 
RT     Room temperature 
S     Serine 
SDS     Sodium dodecyl-sulphate 
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Sf9     Spodoptera frugiperda 
Sia     Sialic acid 
STD-NMR    Saturation transfer difference-NMR 
SUNGA Substitution of N-glycan functions in 
glycosyltransferases by specific amino acids 
SVZ Subventricular zone 
T Threonine 
TCA Tri chloric acetic acid 
TMB 3,3’,5,5’-tetramethylbenzidine  
U Unit 
V     Volume 
W     Weight 
wt     Wild-type 
z     Zebrafish 
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